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Abstract
In 200 B C 5 Hippocrates wrote that “those diseases which medicines 
cannot cure, the knife cures, those which the knife cannot cure, cautery 
cures and those which cautery cannot cure are reckoned to be wholly 
incurable” . This dictum applies well to the management of peptic ulcer 
haemorrhage. In my period of research at the Western General $ I aimed 
to address some aspects of these three corners of management.
I-Cautery :
Endoscopic injection therapy with dilute adrenaline stops bleeding and 
prevent rebleeding from peptic ulcers . No treatment is perfect, 15-25% of 
patients rebleed and require urgent surgery.
My work has examined clinical and experimental approaches of improving 
endoscopic injection treatment.
i-Major peptic ulcer haemorrhage is the consequence of arterial erosion 
and the focus of therapy is to cause thrombosis of the arterial defect. 
Whilst adrenaline probably stops bleeding by causing vasoconstriction , a 
more permanent approach is to inject thrombin into the bleeding ulcer 
.Therefore , 140 patients with significant peptic ulcer haemorrhage were 
randomised to endoscopic injection with adrenaline (70 patients $ group 1) 
or to adrenaline plus human thrombin (70 patients , group 2) . Fourteen 
(20%) group 1 patients and three (4.5%) group 2 patients rebled (p<0.005). 
The 30 day mortality was 10% in group 1 patients and nil in group 2 
patients (p<0.013), Combination of adrenaline plus human thrombin 
injection appears safe and may represent best treatment for bleeding 
peptic ulcers.
reasoned that this action may be of value in reducing arterial blood loss
i fI
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ii-The mechanisms by which endoscopic therapy stops bleeding are unclear 
, and to explore this,experiments were performed in a validated animal 
model in which bleeding mucosal ulcers were treated by a range of 
injection materials , Active ulcer haemorrhage was arrested by an 
adrenaline/thrombin combination whilst other agents including sclerosants 
, hypertonic solution and alcohol were only moderately effective. Arterial 
thrombosis was not effected by any regime , although the 
thrombin/adrenaline combination caused local submucosal thrombosis of 
small vessels which probably act as a haemostatic p lug.
iii-Whilst the immediate outcome of patients treated endoscopically for
,
ulcer bleeding is well documented , late prognosis is unclear.
121 patients treated endoscopically for severe peptic ulcer haemorrhage 
were followed for a median period of 36 months ,and outcome was 
compared with that of age and sex matched controls.
Kaplan-Mieir plots showed reduced survival in ulcer patients (p<0.01) . 30 
patients(26%) died during the follow up period , deaths were largely 
restricted to patients who had co-morbid diseases . 
n-Medicines
Acid reducing agents are extensively used in patients with ulcer 
haemorrhage but there is no evidence that they have any effect on 
morbidity or mortality . This leaves those who fail endoscopic therapy and 
are not fit for surgery at a great risk of death. Octreotide has been used to 
stop variceal bleeding largely by reducing splanchnic blood flow and it was
■s
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from peptic ulcer haemorrhage. Gastroduodenal mucosal blood flow was 
measured in experimental animals using a Laser Doppler Flowmeter. 
Intravenous octreotide infusion markedly reduced gastro duodenal 
mucosal blood flow in a dose dependent manner, without causing any 
systemic haemodynamic disturbance. These findings suggest that this 
agent may be helpful in the management of bleeding from gastroduodenal 
ulcer disease and gastritis and trials of octreotide in peptic ulcer 
haemorrhage are in progress , 
in-The Knife
The optimal emergency operation to stop haemorrhage from peptic ulcers 
is a matter of debate, the answer to this debate could be crucial in 
determining the short and long term outcome.
Sixty seven of 492 patients failed endoscopic therapy for bleeding peptic 
ulcer and underwent emergency surgery in Edinburgh in the period 1990- 
1995 . Simple underrunning was done in 28 patients whilst 39 had more 
radical surgery. The two groups were well matched for risk factors known 
to influence prognosis. Rebleeding was significantly higher in patients 
treated by underrunning (7 versus l)(p<0.015). There were fewer deaths 
in the radically treated group(5 versus 7)(NS) .Patients undergoing 
surgical operation for severe peptic ulcer haemorrhage after failed 
endoscopic therapy may be best served by an aggressive approach .
In conclusion , the approaches of Hippocrates remain appropriate in 1996. Now 
cautery by endoscopic therapy has become the treatment of choice for bleeding
: I:'
ulcers. The knife is reserved for failures of endoscopic therapy, although an 
aggressive scalpel may work better than a conservative on e.
Medicines still have little to offer, although novel approaches using drugs which 
reduce blood flow may be helpful.
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Chapter 1
Introduction
The role of endoscopy in the treatment of peptic ulcer bleeding
INTRODUCTION
111 specialised centres the mortality of peptic ulcer haemorrhage has been greatly 
reduced and now lies between 2 and 6% (Jeans et al 1991 , Hunt et al 1980 , 
Zimmerman et al 1995 , Bramley et al 1993). It is difficult to define a single 
factor responsible for this low mortality and it is unlikely that fiirther reductions 
will occur since some deaths fi'om ulcer bleeding are an agonal event in terminally 
ill patients or occur in very frail elderly patients who have severe comorbid 
diseases. The role of endoscopy in achieving optimum management for patients 
admitted to hospital because of ulcer bleeding relates to obtaining an early, 
accurate diagnosis, provision of prognostic information and delivery of 
haemostatic therapy. Nevertheless it is difficult to prove that diagnostic or 
therapeutic endoscopy improves survival and it is likely that the best outcome is 
achieved by concentration of resources and expert personnel upon the critically ill 
patient leading to proper resuscitation and appropriate use of pharmacological, 
surgical and endoscopic treatments. Endoscopic therapy is only part of the 
management jigsaw and best therapy involves a multidisciplinary approach 
including endoscopists, surgeons, radiologists and experts in intensive care.
Endoscopy is done after the patient has been resuscitated . However out of hours 
emergency endoscopy in the most severely ill patients is often undertaken by 
relatively inexperienced endoscopists in suboptimal surroundings without expert 
nursing assistance. Centres with special interest in gastrointestinal bleeding have 
properly equipped and manned facilities available 24 hours a day. Although the 
great majority of cases can be safely endoscoped during the next working 
day(Choudari et al 1993), some actively bleeding patients do require out of horn's 
endoscopy and resources must be available to manage them.
Pathophysiology
Major bleeding occurs when a peptic ulcer erodes a large artery. Branches of the 
gastroduodenal artery may be involved by posterior duodenal ulcers and branches 
of the left gastric artery can be ruptured by lesser curve ulcers. It is of interest that 
bleeding from ulcers in these sites tends to be particularly brisk (Swain* et al 
1986) . The involved arteries range in size between 0.1 - 1.8mm and it has been 
shown that breaches gieater than 4mm in diameter are unlikely to respond to any 
form of endoscopic therapy (Swain^ et al 1986).
Arteritis is commonly seen in vessels involved by ulcers and this makes 
interpretation of histological changes which follow endoscopic therapy difficult .
For example it may be impossible to quantify the degree of arteritis or thrombosis 
associated with endoscopic therapy when similar changes are an inlierent feature 
of the ulcer process. In addition, the relative infrequency of biopsy material and 
lack of an animal model of ulcer bleeding have greatly limited the ability of 
researchers to define the effects of endoscopic therapy in man.
Haemostatic mechanisms following ulcer bleeding are unclear . The effect of acid 
contents upon clotting is largely unknown although it is clear that blood clot 
stability is impaired by low pH . Detailed understanding of thrombotic 
mechanisms may result in strategies for developing optimal intragastric conditions 
for haemostasis and specific agents which could be applied to the bleeding point. 
Patient selection
Approximately 80% of patients stop bleeding spontaneously (Bornman et al 1985 , 
Clason et al 1986) . Endoscopic or surgical therapy is clearly unnecessary and 
meddlesome in this group. Patients at risk of uncontrolled bleeding tend to be 
elderly, present with hypotension, tachycardia and anaemia. Mortality is high in 
patients who have an upper gastrointestinal haemorrhage while hospitalised for 
other reasons(Zimmerman et al 1994). The presence of significant comorbid 
disease increases the risk of death, particularly if a surgical operation is necessary
(NIH 1989 , Silverstein et al 1981 , Branicki et al 1990 , Peterson et al 1990). The 
most important prognostic factor however is the endoscopic findings (Chang- 
Chien et al 1988 , Lin et al 1992 , Freeman et al 1993 , Foster et al 1978 , Griffiths 
et al 1979 , Storey et al 1981 , Wara 1985). Patients who at endoscopy are found 
to be actively bleeding and who are shocked have an 80% risk of continuing to 
bleed or of rebleeding during that hospital admission . The presence of a non­
bleeding visible vessel (figure 1) is associated with a 50% chance of rebleeding . 
The "visible vessel" represents either a pseudo-aneurysm of the damaged arteiy or 
a sential blood clot (Swain 1990). Although adequate cleaning of the ulcer base is 
necessaiy to define the endoscopic appearances, the endoscopist must be aware 
that disturbing the "visible vessel" can cause brisk, active bleeding.
Adherent blood clot and "oozing" (figure 2&3) have been associated with a 
significant risk of rebleeding rate by some authors(Storey et al 1981, Wara 1985) ; 
others suggest that rebleeding is uncommon and it is my own practice not to treat 
patients who present with oozing or adherent clots from ulcers endoscopically . A 
clean ulcer base (figure 4) is not associated with further bleeding.
Some enthusiasts have advocated the use of endoscopic Doppler devices to 
identify patent arteries within and around the ulcer, and have reported that only
ulcers with a positive Doppler signal should be treated (Beckly et a l , Kohler et al 
1991 , Fullarton et al 1990) .
Endoscopic stigmata of ulcer haemonhage are ephemeral; obviously all patients 
who present with ulcer haemoii'hage have active bleeding at some stage, and the 
frequency with which stigmata are found varies with the timing of endoscopy . For 
example if endoscopy is performed within 12 hours of admission approximately 
70% of ulcers will have important endoscopic stigmata but if endoscopy is 
delayed after 12 hours these endoscopic findings will only be present in 40% of 
comparable patients (Foster et al 1978) . The timing of endoscopy is therefore 
important in interpreting clinical trials of ulcer bleeding therapy.
Despite this observation it is generally agreed that patients who are found to be 
actively bleeding fr om the ulcer and those who present with a non-bleeding visible 
vessel should be treated endoscopically, and those without stigmata should be 
managed conservatively. Surgery is now reseiwed for the failures of endoscopy 
therapy; when access is impossible because of profuse active bleeding or when the 
patients continues to bleed despite apparently adequate endoscopic flierapy.
It is important that the endoscopist knows his/lier limitations . Massive bleeding 
from a major aiteiy does not respond to any endoscopic modality and patients
presenting in this way require early emergency surgeiy; their operation should not 
be delayed by endoscopic therapy which has little chance of success. It follows 
that endoscopic treatments are only valuable in managing moderately severe 
cases. Minor bleeding will settle with supportive therapy, major haemorrhage 
requires an emergency operation whilst the intermediate group of patients benefit 
from endoscopic therapy . This may avoid the need for a surgical operation and 
may reduce transfusion requirements, but because endoscopic therapy has limited 
value in the more profiisely bleeding patients , its impact upon reducing hospital 
mortality is only modest.
Figure 1 An ulcer with a non bleeding visible vessel
Figure 2 An ulcer with an adherent clot
Figure 3 An oozing ulcer
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Figure 4 An ulcer with clean base
End Points
The most important and best defined end point is death. Most series report 
"hospital mortality" although surgical literatuie generally refers to "30 day 
mortality".
In some clinical trials patients randomised to conservative therapy have received 
active treatment once it is clear that they are continuing to bleed or rebleed 
(Rajgopal et al 1991) . Although this approach to a trial can be criticised on 
scientific grounds, in clinical practice it is ethically difficult to deny ill patients 
access to active therapy. These trials therefore show no effect upon mortality 
although analysis of other end points demonstrates efficacy of therapy.
"Rebleeding" is strongly associated with death and it has been known for many |
years that the mortality of patients who rebleed in hospital is tenfold mcreased 
(Bornman et al 1985). Rebleeding rates are therefore used in most series to define 
efficacy of therapy and in many studies rebleeding and uncontrolled bleeding '1
(active bleeding which continues despite therapy) are reported together . 
Unfortunately it is often difficult to know in clinical practice when rebleeding has 
occuiTed . Falls in haemoglobin concentration may be a consequence of 
haemodilution; the passage of melaena or occult blood positive stool can occur for
10
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days after bleeding has stopped; pulse and blood pressure alterations may be due 
to a range of causes . It is usual to define rebleeding as the sudden development of 
haematemesis and/or melaena associated with clinical shock or a rapid fall in 
haemoglobin concentrations of at least 2g/dl over a 24 hour period .
Other end points are subject to many variables which make them less useful . The 
need for a sui’gical operation tends to vary according to institution. For some 
surgeons, the need to transfuse more than 4 units of blood is an indication for an 
operation, whilst others will operate only for active bleeding . Transfusion 
requirements are a crude indication of blood loss, because criteria for transfusion 
also differ widely between clinicians . Duration of hospital admission is a poor 
indicator because it tends to relate more to the presence of comorbid disease rather 
than to the severity of bleeding.
Endoscopic therapy - principles
Haemostatic therapy is based upon the need to thrombose the bleeding artery. 
This carr be attempted by thermal modalities, diathermy, injection of 
vasoconstricting, sclerosing or clotting factors and by mechanical devices (Table 
1).
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TABLE I
Endoscopie treatment for bleeding ulcer
Thermal
Argon laser 
Neodymium YAG laser 
Heater probe 
Electrocoagulation
Injection
Adrenaline
Sclerosants
Alcohol
Thrombin
Other
Topical sprays 
Microwave coagulation 
Mechanical
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Thermal devices - laser photocoagulation
The Argon laser emits visible blne-gieen light energy . Tissue penetration is 
superficial and high power settings are needed to cause a tissue effect.
Experiments in a canine model of ulcer bleeding showed that haemostasis can be 
achieved using the Argon laser with low risk of gastric perforation (Silverstein et 
al 1976) . Three controlled clinical trials involving patients who at endoscopy had 
major stigmata of peptic ulcer bleeding were published in the 1980s (Swain et al 
1981 , Vallon et al 1981 , Jensen et al 1984) (Table II) . Swain et al selected 76 of 
330 patients who presented with gastro-intestinal bleeding, 52 of these were 
randomised to laser photocoagulation or managed conser’vatively . Rebleeding 
episodes (8 in the treated group versus 17 controls) and hospital mortality (0 
versus 7) were significantly lower in treated patients . This, like many studies of 
ulcer bleeding suffers from the criticism of small numbers and selection bias . 
Nevertheless efficacy of Argon laser photocoagulation was also shown by the 
other 2 studies .
Further animal studies suggested that Nd-Yag laser energy may be a more 
appropriate haemostatic tool . The depth of penetration is several millimeters, 
resulting in an immediate obvious tissue effect associated with coagulation within
13
vessels, acute inflammation within the mucosa and submucosa leading to eventual 
scar tissue formation (Silverstein et al 1979) . Studies in mesenteric arteries 
demonstrated that small and medium sized breaches could be sealed although 
holes greater than 0.4mm in diameter continued to bleed (Rutgeerts et al 1981). 
Perforation of an experimental ulcer required relatively large amounts of energy 
and an order of magnitude greater than that associated with arterial coagulation 
(Dixon et al 1979). These characteristics led to the view that Nd-Yag laser 
treatment was more suitable than Argon photocoagulation but it is of interest that 
the clinical efficacy of the two modalities is very similar.
Nd-Yag photocoagulation: technical aspects
Nd-Yag lasers produce infra-red light energy at a frequency of 1064nm. Liglit is 
transmitted via flexible glass fibres using medium power settings of 25-50 watts . 
Tissue effects around the bleeding point are achieved without allowing the probe 
to touch the mucosa . Accurate therapy depends upon assiduous cleaning of the 
ulcer base and active bleeding increases the difficulty of administering optimal 
treatment. Standard safety precautions, particularly involving the use of filters and 
safety locks on doors in the endoscopy suite, are necessary to protect the 
endoscopist and assistants.
14
Clinical trials
Several uncontrolled series suggested that Nd-Yag laser photocoagulation of 
bleeding ulcers is safe and effective . The most notable of these was the large 
series reported by Kieshaber et al (1990) who reported more than 90% efficacy in 
1058 treated patients .
Nine controlled clinical trials of Nd-Yag laser versus conservative therapy have 
been published (Table III). In common with studies of Argon laser therapy, the 
number of patients included m any one study is relatively small. Nevertheless 
criteria for inclusion, particularly endoscopic findings or major stimgata of 
bleeding, are uniform. Meta-analysis is therefore justified and has shown that laser 
therapy reduces the rate of rebleeding and decreases hospital mortality (Cook et al 
1992,H em yetal 1988).
Swain'’'^ et al(1986) randomised 131 patients to laser or conseiwative therapy , 
treatment was administered by one of two experienced endoscopists and objective 
end points were assessed by independent clinicians . Seven of 70 patients treated 
by laser rebled and one of these died in hospital . This contrasted with rebleeding 
in 27 of the 68 conservatively managed patients and eight of these died . These 
differences were statistically significant . However even in the experienced hands
15
of these endoscopists, 19% of patients had ulcers which were inaccessible to 
treatment either because bleeding was severe and obscured the ulcer or because 
the bleeding ulcer was awkwardly situated .
A contrasting study is that reported by Krejs et al(1987) . This two centre 
American trial failed to show benefit for Nd-Yag laser therapy . Nineteen of 85 
treated patients and 18 of 89 consei'vatively managed patients rebled and surgical 
operation rates, hospital mortality and transfusion requirements were virtually 
identical in the two groups .
The reasons for the different conclusions of these studies illustrate many of the 
difficulties associated with clinical trials in this field . Although both trials 
exclusively randomised ulcers associated with major endoscopic stigmata, actively 
bleeding ("unstable") patients who comprise the highest risk categoiy were few in 
the American study. This trial thereby compared outcome in a relatively less 
severe disease group . This is confirmed by a much lower rebleeding rate in the 
American control group compared to that of the London( Swain) study. Patients in 
the study of Krejs et al were also relatively young, with a median age of only 49 
years; much less than reported in all other bleeding studies. Endoscopic therapy 
was administered by a small number of experienced endoscopists in the London
16
study , whilst many more operators were involved in the American tria l. It seems 
likely that some of the American endoscopists were climbing their learning curve 
whilst the Londoners were established experts .
Whilst the effiacy of Nd-Yag laser therapy varies between trials, the studies are 
consistent in demonstrating that treatment is safe. Only one case of laser 
associated perforation having been reported (Krejs et a l) .
Current status
Clinical trials show that both Argon and Nd-Yag photocoagulation are effective 
treatments for bleeding peptic ulcer . Both modalities are safe and reported 
complications are very rare. Laser therapy is at least as versatile as other 
endoscopic modalities since it is also the treatment of choice for vascular 
anomalies (Cello et al 1986) and is effective therapy for the Dieulafoy abnormality 
(Al-Kawas et al 1987) .
Despite these observations, laser is now very little used as haemostatic therapy for 
bleeding ulcer , This is because the machines are expensive and until recently have 
been cumbersome and non-portable . Of all available modalities laser is the most 
demanding for the endoscopist; the no-touch technique and the need to treat 
circumferentially around the bleeding point present great practical difficulties in
17
many bleeding patients . This is reflected by the high inaccessibility rate, reported 
in the clinical trials . Other endoscopic therapies are at least as effective, tend to be 
easier to apply and are cheaper.
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Heater Probe
The heater probe comprises a portable power source in which preset amounts of 
heat energy are transmitted to the teflon coated metal tip of an endoscopically 
positioned catheter; best results are obtained using larger diameter probes at 
medium power settings . The catheter is also fitted with a powerful water jet 
which cleans and irrigates the bleeding point and prevents the tip sticking to the 
ulcer crater. Tamponade can be administered to aid haemostasis and, unlike the 
laser, heat can be applied by tangential application.
Haemostasis probably results from a combination of heat and tamponade . 
Experiments in animals showed that the heater probe was more effective than 
injection therapy in arresting bleeding from canine arteries (Rutgeerts* et al 1989)
Uncontrolled series suggested that the heater probe was effective in clinical 
practice (Storey 1983 , Shorvon et al 1985). In the 1980s small controlled series 
from Fullerton et al (1989) and from Jensen et al(1988) confirmed that 
haemostasis of actively bleeding ulcers can usually be achieved, and that 
rebleeding is infrequent following therapy (Table IV). Tekant et al (1995) 
performed a much larger controlled trial in which 153 patients exhibiting a range
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of endoscopic stigmata associated with peptic ulcer bleeding were randomised to a 
combination of adrenaline and heater probe thermocoagulation or to no 
endoscopic treatment . The two groups were well matched with regard to usual 
risk factors for rebleeding and death, although some patients in both groups had 
minor stigmata such as red or black spots which are not regarded as having 
adverse prognostic significance . Haemostasis was achieved by the heater probe in 
all actively bleeding patients and rebleeding was significantly less common in 
treated patients (5 versus 16 rebleeds, P < .01).
The heater probe and laser have been compared in two clinical trials (Johnston et 
al 1985 , Jensen et al 1984) but neither included sufficient patients to show 
differences in outcome. Pap(1987) also failed to show differences in efficacy 
between the heater probe and multipolar coagulation . These trials, limited as they 
are, therefore show little to choose between thermal methods for controlling ulcer 
bleeding . The lower cost, ability to apply tamponade and to coagulate using 
tangential application suggest that heater probe is a better buy than laser for 
treating ulcer haemorrhage.
The more important comparison is between the heater probe and injection therapy. 
The first clinical trial which compared these approaches was reported by Lin et
22
al(1990) .One hundred and thirty seven patients who presented with active 
bleeding or a non-bleeding visible vessel were randomised to heater probe, 
injections with absolute alcohol or conservative (no inteiwention) therapy, hiitial 
control of bleeding was better with the heater probe than with injection (98% 
versus 67%, P <0.04) and permanent haemostasis was achieved significantly more 
often in patients treated by the heater probe, than injection or consei’vative 
management (91%, 67% and 52% respectively). The efficacy of injection 
treatment described in this study is rather less than reported in most other series. 
No complications followed endoscopic intervention. The second study, reported 
by Chung et al(1991), randomised 132 patients who had endoscopic evidence of 
active bleeding to injection with dilute adrenaline or to the heater probe . 
Bleeding was initially controlled in 83% of injected patients compared to 95% of 
heater probe treated patients (P < .05) . The apparent advantage of the thermal 
method has to be balanced by the development of ulcer perforation in two patients 
who received heater probe therapy . The third study reported by Choudari et 
al(1992) randomised 120 patients who presented with a range of endoscopic 
stigmata to 1:100,000 adrenaline plus 5% ethanolamine or heater probe 
coagulation . Permanent haemostasis was achieved in 87% of injected patients and
23
85% of heater probe treated patients . Other end points were similar in the two 
groups . No complication of therapy occurred in any patient.
These studies therefore suggest that the heater probe and dilute adrenaline have 
similar efficacy and (although data are rather limited) that the heater probe is 
superior to sclerosant injection . In clinical practice however these differences are 
not always clearcut and the tecliniques are complementary . For example the 
capacity of the heater probe to apply tamponade and its powerful irrigation 
channel make it suitable for some ulcers which have a large amount of semi­
adherent blood clot and which makes the ulcer difficult to inject. On the other 
hand the heater probe may be rather awkward to manoeuvre within a deformed 
duodenal cap whilst injection treatment can sometimes be more easily 
administered . A well equipped bleeding unit should therefore have equipment and 
expertise for both modalities.
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{Electrocoagulation
Electrocoagulation devices aim to stop bleeding by passing an electric current 
through the bleeding area.
Monopolar units apply a ball tipped probe to the bleeding area and the electrical 
circuit is completed tluough a plate attached to the patient . The earlier probes 
often precipitated bleeding because they adliered to the ulcer bed . These probes 
were also associated with unpredictable tissue damage and the need to frequently 
clean the tip . The liquid monopolar probe has an electrical conducting fluid 
between the tip and the mucosa and this largely overcomes the problem of tissue 
adherence . Three studies have examined monopolar probes in the context of 
controlled clinical trials (Table V) . The largest study was reported by Freitas et 
al(1985) who randomised 78 patients presenting with a range of endoscopic
'I
findings to electrocoagulation using a liquid monopolar electrode or to sham 
treatment. Permanent haemostasis was achieved in 19 of 36 treated patients, but a 
high proportion of the control group had spontaneously stopped bleeding and did 
not rebleed.
26
These rather unimpressive results, associated with an unpredictable tissue damage 
has largely resulted in monopolar electrocoagulation being superseded by other 
contact methods, particularly the multipolar coagulation system.
Bipolar coagulation works by completing an electrical circuit between probes 
applied to the mucosa. The patient plate is umiecessary; tissue penetration and 
damage is more predictable than that associated with monopolar 
electrocoagulation . In experimental animals, the best system is the multipolar 
electrocoagulation pulse, known as BICAP (Laine 1991) . This has three pairs of 
electrodes on its side and tip and electrocoagulation occurs if any pair of 
electrodes are in tissue contact, allowing tangential treatment . Power settings of 
7-8 lasting 1 second are applied circumferentially around the bleeding point until 
blanching occur s, and the probe is then directly applied to the bleeding point. 
Controlled clinical trials with BICAP have reported varying outcome (Table VI) . 
O'Brien et al(1986) randomised 204 patients who were found at endoscopy to have 
either active bleeding or a non-bleeding visible vessel. Seventeen of 101 treated 
patients continued to bleed or rebled compared to 34 of 103 sham treated 
consei-vative patients, P < .01. The greatest benefit was found in the subset of 
patients who had active bleeding; haemostasis was achieved in 24 of 40 patients
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with spurting haemorrhage whilst spontaneous haemostasis occurred in only 8 of 
13 actively bleeding controls . These, and other authors, commented that bleeding 
can be precipitated by application of the probe . This can usually be stopped by 
further BICAP treatment, although this is not invariably possible and catastrophic 
bleeding has followed BICAP therapy.
Brearley et al(1987) examined the BICAP in 41 bleeding patients and found no 
benefit for active treatment. Similar lack of benefit was reported by Goudie et 
al(1984) and by Kernohan et al (1984) .
hi contrast, Laine( 1987& 1989) reported two trials in which prognosis was 
improved using BICAP . In the first of these , he studied 44 patients who 
presented with severe gastrointestinal bleeding from a range of causes . Twenty 
four of these patients were actively bleeding from peptic ulcers . Blood transflision 
was less in the 10 treated ulcer patients compared to the 14 control ulcer subjects. 
The duration of hospital admission and costs of hospitalisation were also less in 
the treated group. Clearly this very small study is insufficient to confirm efficacy, 
but benefit was also reported in a larger study performed by the same author . In a 
clinical trial involving 75 patients who exclusively had non-bleeding visible 
vessels within ulcers, patients were randomised to BICAP or sham treatment.
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Rebleeding occurred in 18% of treated patients compared to 41% of controls; 
blood transflision requirements and need for surgery were lower in the BICAP 
group. Subsequently Laine(1990) and Waring et al(1991) reported similar 
outcome for patients treated using BICAP or injection sclerotherapy.
It therefore appears that European experience of BICAP is disappointing 
compared to that reported in the USA . The reasons for these differences may 
relate to trial design; certainly the number of patients included in European trials 
are greater than those reported by Laine. It is possible that the expertise of a 
single therapeutic endoscopist is a factor in the American studies . An important 
consideration relates to probe size which was larger in the series reported by Laine 
(3.2 versus 2.3mm) and this may have allowed better tamponade and more 
effective coagulation . Technical details are often scantily reported in these 
papers, but it does appear that Laine applied more electrical treatment than was 
given in the European studies.
In summaiy it is probable that electrocoagulation carries modest benefit in ulcer 
bleeding . It may be most suitable for active bleeding . Wonies include 
precipitation of active haemorrhage by the probe and one reported perforation 
after BICAP therapy.
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INJECTION THERAPY
Injection therapy for peptic ulcer bleeding is now widely used as first line 
treatment . Clinical trials show that the approach is as effective as other options 
and that treatment is safe and cheap.
Many questions remain unanswered however; these include the mechanism of 
action, the optimum injection solution and whether injection should be combined 
with other approaches including thermal modalities.
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Mechanisms (Figure 5)
It is not clear how injection therapy stops active bleeding and prevents rebleeding. 
This is because operative specimens following injection therapy are rarely 
available and it is difficult to differentiate the effects of treatment from the 
histological characteristics of a chronic ulcer. Inflammation, vasculitis and 
thrombosis of vessels are an inherent feature of peptic ulcer . Furthermore an 
appropriate reproducible animal model of bleeding peptic ulcer is unavailable.
Injection Treatment for Bleeding Peptic Ulcer
Ulcer Crater VisibleVessel
MuscularisMucosae'
Sub Mucosa
Serosa
Figure 5 1-The ulcer bleed is due to erosion of a major submucosal artery and disruption of
the Muscularis Mucosae 
2-The serosa is rarely involved 
3-Injection is usually directed beside the visible vessel to induce tamponade , vasoconstriction
, dehydration or sclerosis
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The efficacy of injection therapy may be due to one or all of the following 
mechanism.
(i)-Tamponade : Injection of fluid into a fibrotic, rigid ulcer causes compression of 
the bleeding vessel. This hypothesis is supported by the results of the clinical trial 
reported by Lin et al(1993) in which injections of saline or dilute dextrose into 
bleeding ulcers were more effective than conseiwative therapy and had similar 
efficacy to absolute alcohol injections . Similar conclusions were reported by Lai 
et al (1994 ) who showed that endoscopic injection of water stopped bleeding and 
prevented ulcer rebleeding . Fleig et al(1994) speculated whether the efficacy of 
injection therapy was due to the tamponade effect of the solute rather than the 
pharmacological effect of the solvent.
In animal models of gastrointestinal bleeding it is not possible to show that 
haemostasis can be achieved by injection of inert fluids , (Rutgeerts* et al 1989 , 
Rajgopal 1992) although these models do not involve chronic ulceration and 
fibrosis, limiting any tamponade effect . Larger clinical trials are needed to 
examine the effect of injection therapy using inert substances.
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(ii)~Vasoconstriction : Dilute adrenaline stops active bleeding in models of 
gastrointestinal bleeding (Rutgeerts* et al 1989 , Rajgopal 1992) and in clinical 
practice (Chung'^ et al 1988 , Steele et al 1989) . This is presumed to be due to 
vasoconstruction of the bleeding artery although atheromatous change in the 
vessel, peri-vascular fibrosis and inflammation may reduce the capacity of the 
artery to contract . Most endoscopists inject relatively large volumes of dilute 
adrenaline and tamponade may also be important. Blanching around the injected 
area occurs at the time of adrenaline injection; the gastric mucosa of dogs looked 
"cyanotic" when injected with dilute adrenaline (Rutgeerts* et al 1989) . In these 
experiments histological examination showed that inflammation is completely 
localised to the injected area and that necrosis and vascular changes rarely occur 
after injection of adrenaline.
Whether adrenaline is effective entirely by causing vasoconstriction is unclear . In 
clinical trials dilute adrenaline injections not only stop active bleeding, but also 
largely prevents rebleeding (Choudari et al 1994 , Chung et al 1993) suggesting 
that it may thrombose the ruptured artery . This is likely to be simply a 
consequence of vasoconstriction, but adrenaline induced alteration of platelet
35
function (Chung* et al 1988 , O'Brien 1963)and stimulation o f the coagulation
cascade may also be a factor.(figure 6)
X N O :  ^:X : AbE :0 . BIRTH:  
22/03  95 
. 3 : 17 : 4 ' /
• I I   ' !
Figure 6 Tissue oedema and blanching after the submucosal injection of a bleeding ulcer
with dilute adrenaline
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(iii)-Sclerosants : PoHdocanol, ethanolamine and sodium tetradecyl sulphate are 
widely used sclerosants . When injected into the gastric mucosa of dogs differing 
concentrations of polidocanol caused extensive necrosis and deep ulcers in a dose 
dependent manner (Rutgeerts* et al 1989 , Randall et al 1989) .Venous tlnombosis 
invariably follows sclerosant injection but endarteritis and arterial tlrrombosis 
occurs less often . Indeed in a rabbit model , ethanolamine injections temporarily 
increased the rate of bleeding and were not associated with tlii’ombosis of major 
arteries (Rajgopal et al 1992).
One clinical trial has reported that sclerosant injections are useful in stopping 
active bleeding(Wordehoff et al 1982) but most authorities consider that if 
sclerosants have a role it is likely to be in prevention of rebleeding rather than 
treating active bleeding.
(iv)-Alcohol ; 98% ethanol injections cause profound dehydration of tissues 
leading to vigorous inflammation, extensive necrosis and ulcer formation 
(Rutgeerts* et al 1989 , Randall et al 1989). Surrounding areas are congested and 
hyperaemic and blood vessels are partially tlorombosed, yet often permiable . In 
experimental models active bleeding is rarely stopped by alcohol injection .
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(v)"Clotting factors : Injections of bovine thrombin initiate the clotting cascade. 
Several small studies show value for injection of bleeding peptic ulcers(Benedetti 
et al 1991 , Balanzo et al 1990 , Groitle et al 1987 , Herold et al 1994) although no 
study has been large enough to define comparative efficacy with other modalities.
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Controlled clinical trials
Many uncontrolled series performed in the 1980s suggested that injection therapy 
improved outcome in patients who presented with major ulcer bleeding . Inclusion 
criteria are often poorly, defined in these reports which are subject to the usual 
criticisms of open trials, but their conclusions have largely been confirmed by 
randomised controlled clinical trials.
Relatively few studies have compared injection with no-injection in matched 
groups of patients but clear advantage for injection has emerged and it can be 
argued that trials which include a no-treatment control arm have become 
unethical.
The optimum injection regime stops active bleeding, prevents rebleeding and has 
no complications. Many combinations of injection solutions have been examined 
but none as yet completely fulfils these requirements.
aVDilute Adrenaline : Chung and collègues have pioneered the use of dilute 
adrenaline . hi a controlled trial patients who presented with actively bleeding 
ulcers were randomised to endoscopic injection with 1:10,000 adrenaline or were 
managed without endoscopic therapy (Table VII) . Injected patients required 
significantly less blood transfusion, needed fewer emergency surgical operations
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and had a shorter hospital stay than conservatively managed patients . 
"Rebleeding" is not reported in this paper and mortality was similar in both 
groups.
Several groups subsequently performed trials in which adrenaline was combined 
with injections of sclerosants (Rajgopal et al 1991 , Panes et al 1987 , Balanzo et 
al 1988 , Oxner et al 1992). This was done because of the preconception, 
supported by experiments in animal models that adrenaline would not cause 
thrombosis of the bleeding artery . Whilst adrenaline should stop active 
haemorrhage by causing vasoconstriction, the argument ran that a sclerosant was 
necessary to induce vascular damage and promote intra-arterial thrombosis. To 
test this assertion, two clinical trials compared outcome in patients treated with 
dilute adrenaline with that of matched patients treated by a combination of 
adrenaline and a sclerosant. Chung et al (1993) randomised 200 actively bleeding 
patients to injection with 1:10,000 adrenaline (99 patients) or to adrenaline 
followed by 3% sodium tetradecyl sulphate (101 patients). The groups were well 
matched in all relevant respects . Initial haemostasis was achieved in almost all 
patients, in fact the only failures were those in whom torrential bleeding prevented 
visualisation and injection of the bleeding ulcer . After initial control of bleeding
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only two patients in each group rebled in hospital. Similar conclusions were 
reached by Choudari et al (1994) who randomised 107 patients who presented 
with a range of major endoscopic stigmata to injection with 1:100,000 adrenaline 
or to adrenaline plus an injection of 5% ethanolamine. Permanent haemostasis 
was achieved in 85% of patients in both groups.
These two studies clearly show that the addition of a sclerosant to an injection of 
adrenaline is umiecessaiy. This suggests that in clinical practice, adrenaline does 
induce thrombosis of the bleeding vessel, underlying deficiencies in animal 
models of ulcer bleeding.
Other series have compared the outcome of patients treated by injection therapy 
with patients treated using thermal methods . Loizou et al(1991) randomised 42 
patients to 1:10,000 adrenaline or a combination of adrenaline and Nd-Yag laser 
photocoagulation . Not surprisingly this small study had insufficient power to 
show significant differences between these treatments although there was a 
tendency for combination therapy to be more effective, as suggested by a 25% 
rebleeding rate in the injected group compared to a 14% rebleeding rate following 
laser and injection . Carter et al(1994) compared adrenaline injection with Nd-Yag 
laser therapy . Permanent haemostasis was achieved in 96% of laser treated
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patients and 81% of injected patients but this apparent difference was not 
statistically significant because of small sample size (44 patients).
The effective concentration of adrenaline is not known . The Hong Kong group 
have used a concentration of 1:10,000 whilst the Edinburgh group have favoured a 
1:100,000 solution . The results of endoscopic therapy are very similar in trials 
reported by these two centres. Significant and potentially important increases in 
plasma adrenaline concentrations follow endoscopic injection with 1:10,000 
adrenaline solutions(Sung et al 1994) , and this could have adverse efffects in 
patients who have co-existing cardiac diseases . In clinical practice no significant 
complications have been reported following adrenaline treatment.
Dilute adrenaline is the injection treatment of choice for active ulcer bleeding and 
clinical trials show it to be at least as good as any other approach . For patients 
with non-bleeding visible vessels there seems little to choose between adrenaline 
and alternative therapies. Combination of adrenaline injection and a thermal 
method is attractive because the bleeding source is treated by several approaches . 
As yet few clinical trials have adopted this approach although Chung et al (1994) 
and Tekant et al(1995) have shown that combination of adrenaline and the heater 
probe is safe and effective . Studies proving that combination treatment is better
42
than a single agent approach will require large numbers and almost ceilainly 
multicentre participation.
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(h)-Sclerosants : A range of sclerosing agents have been injected directly into and 
around bleeding ulcers to try and stop active bleeding and prevent rebleeding . 
These include 1% polidocanol, 5% ethanolamine and 3% sodium tetradecyl 
sulphate.
Several uncontrolled series (Sohendra et al 1985 , Kortan et al 1986) performed in 
the early 1980s suggested that injection of these agents was effective and safe . 
There are however no controlled trials in which outcome has been assessed in 
patients randomised to sclerosants or to conservative (no injection) treatment. 
Several trials have compared the efficacy of sclerosant injection with other 
haemostatic methods . For example Benedetti et al(1991) randomised patients 
presenting with bleeding from a range of sources to injection with 1% polidocanol 
or to thrombin injection and showed similar haemostatic effect for these 
treatments . Strohm et al(1994) randomised patients to one of four treatment arms 
(fibrin glue, 1% polidocanol, dilute adrenaline or adrenaline plus polidocanol) and 
showed little advantage for any one approach . These two trials have insufficient 
power to demonstrate that polidocanol injection is better than other approaches 
but even in the small numbers involved in these studies, low rebleeding following 
1% polidocanal injection in patients with endoscopic stigmata of major bleeding
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does suggest that this agent is effective . Pulancie et al (1995) randomised 315 
patients with peptic ulcer haemorrhage (Forrest Class la&b and Ila&b) to injection 
with 1% polidocanol (n=160) or Nd YAG Laser(n=155) they reported a success 
rate(permanent haemostasis of 90 and 94 per cent respectively(NS) . Finally 
Rutgeerts^ et al(1989) also showed that injection of polidocanol is as effective as 
Nd-Yag laser photocoagulation therapy in patients with ulcer bleeding.
More studies have examined the effectiveness of combination adrenaline and 
sclerosant regimes. (Table VIE) The controlled trial reported by Panes et al (1987) 
involved 113 patients who were randomised to a combination of 1:10,000 
adrenaline plus 1% polidocanol or to no injection. Recurrent bleeding occurred in 
5.5% of injected patients, compared to 43% of controls (P< .001), with 
corresponding reduction in need for emergency surgery, blood transfusion and 
duration of hospital admission . Rajgopal et al(1991) subsequently showed that the 
combination of 1:100,000 adrenaline plus 5% ethanolamine reduced rebleeding 
rates (12.5 versus 47%, P < .001) in patients who had a range of major endoscopic 
stigmata . In this study some control patients were injected when they rebled, most 
then avoided emergency surgery, but this questionable defect of trial design 
resulted in loss of potential difference in other possible end points . Moreto et
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al(1992) showed in a small clinical trial (38 patients) that haemostasis was 
achieved in patients treated by a combination of ethanolamine plus tlirombin 
injections (one of 19 treated patients developed uncontrolled bleeding, compared 
to fiirther bleeding in eight of 19 controls).
The role of the sclerosant in these trials is difficult to interpret for two major 
reasons . Firstly because the trials suffer from the common problem of small 
sample size . Secondly, because the sclerosant has invariably been injected in 
combination with another agent which has proven therapeutic value . To try and 
define the role of the sclerosants three studies have compared outcome in patients 
randomised to adrenaline injection with that following a combination of 
adrenaline and a sclerosant.
As previously described, the trials reported by Chung et al(1993) and by Choudari 
et al (1994) showed little advantage for combination therapy over an injection of 
adrenaline alone . A third study reported by Villanueva* et al(1993) showed 
similar outcome following injection with adrenaline plus polidocanol or treatment 
with adrenaline alone. (Table IX) No study has compared haemostasis in patients 
treated by dilute adrenaline with that achieved by injection of a sclerosant alone.
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Sclerosant injections have been associated with serions complications . These 
presumably occur as a consequence of extensive thr ombosis of arteries serving the 
upper gastrointestinal tract. Levy et al (1991) reported a fatal case of gastric antral 
necrosis following injection with a combination of adrenaline and sodium 
tetradecyl sulphate . Similar complications following sclerosant injections have 
been reported by several authors (Loperfrds et al 1990 , Chester et al 1990) . 
Luman et al (1995) reported common bile duct stricturing causing obstructive 
jaundice after repeated injection of a posterior duodenal ulcer with adrenaline and 
5% ethanolamine.
Because sclerosants appear to offer no advantage over injection with adrenaline 
alone and because of these unusual but potentially serious side effects, I do not 
believe that sclerosants have a role as injection therapy for bleeding ulcers.
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(cVAlcohol : The efficacy of injections of 98% ethanol has been examined in 
several clinical trials (Table X). Sugawa et al (1986) repoited effective 
haemostasis in actively bleeding ulcers and this was confirmed in a randomised 
trial performed by Pascu et al (1989) . More recently Lazo et al (1992) reported a 
study of 39 patients who were found at endoscopy to have non-bleeding visible 
vessels within the ulcer base . Twenty five patients were treated by alcohol 
injection and 14 acted as non-injected controls . Rebleeding was significantly less 
common in the injected group (8 versus 57%, P < .01) . Lin et al (1993) repoited 
that alcohol injection stopped active bleeding and prevented rebleeding in 86% of 
patients whose ulcers were injected with alcohol although a similar proportion of 
ulcers treated with 3% sodium chloride (68%), 50% dextrose (78%) and normal 
saline (78%) also achieved permanent haemostasis.
As already stated (Rutgeerts* et al 1989 , Randall et al 1989) injection of alcohol 
into the gastric mucosa of dogs caused deep ulcers and such ulcers also 
commonly occur in the human oesophagus following injection sclerotherapy for 
varices . It is perhaps not surprising therefore that ulcer perforation has been 
repoited following alcohol injection into a bleeding ulcer (Lin et al 1993).
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One small study (Chiozzini et al 1989) has compared the efficacy of alcohol with 
dilute adrenaline injection therapy (but had insufficient power to detect differences 
in efficacy). A much larger study is needed . The evidence that alcohol stops 
active bleeding and prevents rebleeding is more convincing than that for the 
sclerosants ethanolamine, polidocanol and STD . The potential for side effects 
induced by injection is probably higher for alcohol than for adrenaline, and this 
may deter such a study.
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(d)-Thrombin : Direct injection of thi'ombin into a bleeding nicer may represent 
the most effective method of sealing the bleeding vessel . Gi'oitl et al (1987) 
injected bovine thrombin into ulcers of 11 patients halting active bleeding and 
prevented rebleeding . They also suggested that the agent may have value in 
sealing anastomotic leakage.
Balanzo et al (1990) randomised 64 patients who presented with active ulcer 
bleeding to 1:10,000 adrenaline or to a combination of 1:10,000 adrenaline plus 
thrombin . Permanent haemostasis was achieved in 81 and 84% of both groups 
respectively . Benedetti et al (1991) randomised 82 consecutive patients who 
presented with peptic ulcer bleeding to 1% polidocanol (n=28) or thrombin (n=54) 
injections . Permanent haemostasis was achieved in 82% of polidocanol injected 
patients and 87% of thrombin treated patients . (Table XI)
Thrombin injection therefore does seem at least as effective as other modalities, 
although the clinical trials have insufficient power to show whether it is any better 
(or worse) than other approaches . A trial which could define such differences 
would have to be extremely large since standard injection treatment is relatively 
effective and because at least some of the failures of each modality are due to
54
inaccurate localisation of the injected material rather than to differences in the 
capacity of these materials to thrombose vessels.
A particular risk of thrombin injection is that it could precipitate extensive 
intravascular thrombosis . In clinical practice this has not been observed either in 
patients injected for peptic ulcer or variceal bleeding . Bovine thrombin also 
carries the theoretical risk of inducing anaphylaxis and it may be unwise to 
repeatedly inject the same patient with this material.
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Other approaches Endoscopic haemostasis has been attempted by topical 
application of a range of substances including collagen haemostat (Feld et al 
1981), clotting factors (Linscheer et al 1 9 7 7 ) , cyanoaciylate tissue glues (Peura et 
al 1982) and metallic sluiries as pait of ferromagnetic tamponade (Smith et al 
1990 , Carlson et al 1990) . Experience in animals and man has largely been 
disappointing but is rather limited.
Mechanical approaches have included metal clips (Binmoeller et al 1 9 9 3 ) , rubber 
band ligation (Swain et al 1985) , balloon tamponade (Taylor et al 1996) and 
sewing (Escouitow et al 1990) . Each has its enthusiasts but cannot as yet be 
recommended m clinical practice.
A microwave coagulation method has been devised for endoscopic use . 
Microwave energy produces heat dielectrically based on molecular motion 
produced by ultra-high frequency excitation . The electrical field is well localised 
to the tip of the electrode and risk of perforation is theoretically low. In 
experimental models microwave coagulation performs as well as the heater probe 
and BICAP and better than injection with adrenaline and 1% polidocanol 
(Michaeltz et al 1989) . One prospective clinical trial (Panes et al 1991) involving 
127 patients presenting with a range of endoscopic findings associated with peptic
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ulcer bleeding, randomised patients to endoscopic sclerosis using adrenaline and 
polidocanol or to microwave coagulation . No complications occurred in either 
group and rebleeding, sui'gical operation and transfusion rates were similar in both 
groups .
The main drawback of the microwave coagulation probe is adherence to the 
bleeding point. Although this can be usually overcome by application of a 
dissociation electrical current, precipitation of further bleeding can sometimes be 
serious. A no-contact method in which sparking across to the bleeding point has 
been studied in experimental animals but has not yet been applied to man 
(Kalabakas et al 1993).
Failures of endoscopic therapy
It can be argued that endoscopists can adversely affect outcome in patient who fail 
endoscopic therapy . Repeated endoscopy, large blood transfusion and delayed 
surgical operation in patients who ultimately fail attempted endoscopic 
haemostasis all increase risks of death . Unfortunately we cannot predict the 
failures of endoscopic treatment . Clearly patients with the most active, profuse 
haemorrhage are the least likely to respond to non-operative approaches both 
because massive bleeding can make adminstration of endoscopic therapy
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impossible and because large holes in major arteries are unlikely to respond to any 
endoscopic therapy . Tlius, patients who are shocked with active bleeding from a 
large(>2cm in diameter) posterior duodenal ulcer tend to comprise the failures in 
clinical trials (Choudari et al 1994 , Villaneuva^ et al 1993 , Brullet et al 
1991&1996) . Nevertheless even in these patients the Edinburgh group reported 
75% success with treatment by injection or heater probe (Choudari et al 1994) , 
One approach in the highest risk patients is early repeat endoscopy with further 
treatment even in the absence of rebleeding . Villanueva et al (1994) suggested 
that such a policy might improve outcome .
Best policy in patients who rebleed after endoscopic treatment is not clear . Many 
endoscopists tend to retreat such patients, whilst others believe that rebleeding is 
an indication for surgical intervention . Clinical trials do not tell us when to 
operate and although an aggressive, early surgical approach has been reported to 
be best for elderly patients presenting with major ulcer bleeding (Morris et al 
1984), we have no data supporting this for patients receiving endoscopic therapy . 
No study has compared surgical against endoscopic therapy . Most trials of 
endoscopic therapy define need for a surgical operation as a treatment failure . An 
alterntive view is that endoscopic control of bleeding facilitates safe, early elective
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surgery . A successful outcome in an individual patient often depends upon a 
combination of endoscopic and surgical approaches and good management is a 
team approach.
Chapter 2
Experimental studies of injection in ulcer haemorrhage
61
Introduction
Peptic ulcer haemoiThage can be stopped by a range of endoscopic injection 
therapies . A variety of solutions have been used but in a series of clinical trials , 
the best regime has not been defined . Furthermore , the mechanisms by which 
injection therapy thromboses the bleeding artery withm the ulcer bed are unclear 
. Such mechanisms may include (i)-vasoconstriction(Rutgeerts et al 1989 , 
Pinkas et al 1995) ; (ii)-compression of the bleeding vessel by local oedema 
“tamponade” , Lai et al (1994) demonstrated that local tamponade with distilled 
water is as effective as diluted adrenaline in the treatment of patients with ulcer 
bleeding), (iii)-sclerosis and endarteritis (demonstrated by Rutgeerts after 
injection of polidocanol) and (iv)-dehydration (Leung et al 1991&1989 ,
Chung* et al 1991) .
It is difficult to study these effects because an adequate animal model of peptic 
ulcer bleeding is unavailable . Experiments have largely involved gastric 
mucosal bleeding induced by various ulcer making devices (Rajgopal et al 1992 
, Whittle et al 1991 , Protell et al 1978 , Chung et al 1991) and this is far 
removed h orn the clinical situation of bleeding from a chr onic ulcer in which a 
major aifery is eroded by a clnonic inflammatory process . Nevertheless 
experiments involving bleeding from acute ulcers have yielded valuable 
information concerning the effect of endoscopic treatments and these have 
stimulated clinical trials of injection therapy in man .
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Ill a previous study Rajgopal et al 1991 showed that injections of dilute 
adrenaline (but not saline) stopped active bleeding from acute gastric mucosal 
ulcers in anticoagulated rabbits , whilst sclerosants increased the rate of 
bleeding . Histological examination showed that adrenaline did not cause 
arterial thrombosis and that sclerosants induced severe local inflammation , 
necrosis and venous thrombosis but these changes were not followed by 
endarteritis or arterial thrombosis .
These experiments prompted a clinical trial in which it was demonstrated in 
patients admitted to hospital because of bleeding peptic ulcer that a combination 
of adrenaline and ethanolamine conferred no extra advantage over injection with 
adrenaline alone (Choudari et al 1994).
Adrenaline does not always stop ulcer bleeding ; failures are likely to be due to 
continued patency of the defect within the bleeding artery . One approach to 
thr ombosing the artery is local injection of thrombin . In this study I have 
compared the acute haemostatic effect of injection with dilute adrenaline , the 
sclerosant ethanolamine and human thrombin using a previously validated 
(Rajgopal et al 1991) model of acute mucosal bleeding .
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Methods
Gastric mucosal injury was induced in anaesthetised rabbits and the effects of 
injections were observed in acute and semi acute experiments .
( l) -A c u te  b le e d in g  ex p erim en ts
Experiments were carried out in 6 NewZealand white rabbits with a median 
weight of 3.22kg (2.3-3.75 k g ). hitravenous midazolam 0.6 mg/kg and 
intramuscular fentanyl citrate 0.315 mg/ml and Fluanison lOmg/ml (0.22 ml/kg) 
was used to induce anaesthesia . All animals received continuous supplementary 
oxygen through a face mask at 6 1/min .
The animals received two 300 mg Aspirin tablets , 24 and 12 hours before the 
procedures and also received a bolus injection of 500 U of intravenous heparin , 
followed by 500 units/kg/hour of heparin injection into an ear vein . A median 
laparotomy and anterior gastrotomy were performed with careful haemostasis . 
Ulcers were created by excising mucosal discs of 2.5-4mm in diameter using a 
scalpel. Randomly chosen discs were examined by an independent histologist 
(A.Lessells.). This revealed mucosa alone in all cases . Bleeding from each 
wound was initially measured by a volumetric beaker and as the bleeding 
volume decreased by a pre-weighed segment of blotting paper . Measurements 
were carried out at 1, 2,3,4,5,10,20 and 30 minutes after ulcer induction . Only 
wounds bleeding in excess of 1.5 ml/min (basal blood loss) for one minute were 
studied.
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A total of thirty eight ulcers(blood loss>1.5ml/min) were created in 6 rabbits . 
These were then randomised to
(a)-Control-no injection.
(b)-Two 1 ml injections of 50% dextrose around the mucosal wound .
(c)-2 mis of 1 : 100,000 adrenaline .
(d)-2 mis 5% ethanolamine .
(e)"2 nils human thr ombin (400 lU) suspended in 16 mM calcium chloride 
(donated by Scottish Blood Transfusion Service).
(f)“l ml of human thrombin (200 lU) plus 1 ml of human fibrinogen (50 mg) .
(g)-Spray of thr ombin/fibrinogen mixture (2 mis) within 3 mm of the ulcer . 
This was done using a double channel sclerotherapy injection needle which 
allow simultaneous discharge of the injected material which was sprayed over a 
30 second period.
hijections were given in random order (different treatments were used in ulcers 
created in the same animal) using a standard 25G needle with an outer diameter 
of 0.6 mm . At the end of the experiment, the animals were killed by an 
overdose of barbiturate . The stomach was removed , fixed in formalin and 
examined by an independent histo-pathologist (A.L.) who was unaware of the 
injection given.
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(2 )-S em i-a cu te  ex p er im en ts
Four further rabbits with a median weight of 3.2 kg (range 3.1-3.3 kg) were 
intubated and ventilated . Upper gastrointestinal endoscopy was performed 
using an Olympus P 10 paediatric forward viewing gastroscope (Olympus , 
Keymed, South end on sea , U K ). Superficial mucosal injury was induced 
using a standard biopsy forceps (26N) (Olympus , Japan) in the body and 
antrum of stomach . The ulcerated areas were then injected endoscopically with 
1 ml of 1: ! 00,000 adrenaline plus 1 ml tlirombin (200IU)(n-2), 2 ml 5% 
ethanolamine or 2 ml 98% alcohol. Injections were carried out using a variceal 
sclerotherapy needle (25G) . Injection sites were marked with methylene blue, 
Two out of those four animals survived post operatively and were killed after 1 
hour and 60 hours respectively . The other two animals (injected with 98% 
alcohol and 5% ethanolamine respectively) suffered an anyphalactic reaction 
and died 4 hours post-operatively. This occurred despite the presence of a 
Home Office veterinary surgeon who intubated and ventilated the animals and 
supervised the procedure . It was her opinion that the anaphylactic reaction and 
death was secondary to the injected material rather than other technical factors .
(3 )-E x p erim en ts  in v o lv in g  p e r ip h e r a l  (ear) a r te r ie s
In 5 rabbits(also used for gastro-intestinal experiments) injections of 2 ml of 
1:100,000 adrenaline alone , adrenaline plus thrombin(200 lU ), 5% 
ethanolamine , 98% alcohol, fibrinogen(100mg) and 50% dextrose were 
randomly placed next to the ear central
66
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artery . Animals were killed 2 hours(3 rabbits) or 56 hours(2 rabbits) later and 
the ear sections examined histologically.
Statistical Analysis
Changes in bleeding volume were plotted out and the integrated blood loss for 
each modality was measured as the area under the curve . Statistical difference 
between the various groups was measured using the Mann-Whitney U te s t. 
Significance level was considered as p<0.05 .
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Results
(1 )- A c u te  b le e d in g  ex p erim en ts
Basal blood loss was similar in all ulcers , mean L87(SD=0.31) ml/min (n=38) 
with the exception of 2 ulcers which were subsequently injected with 50% 
dextrose . By chance these ulcers bled more profusely than controls and those 
receiving other treatments.
Bleeding rate was relatively constant in control ulcers over a 30 minutes period 
(Tablet).
All haemostatic agents significantly reduced integrated blood loss although 
adrenaline plus thrombin and sprayed fibrin sealant tended to be the most 
effective . The difference between the various modalities did not achieve 
statistical significance (Table I Sc figure 1), Indeed both of these rapidly 
stopped active bleeding and this did not recur over the experimental period . 
Injected fibrin sealant, 5% ethanolamine and 50% dextrose injections did not 
significantly decrease initial blood loss , but did tend to reduce bleeding rates
3i
within 20 minutes . As anticipated adr enaline alone immediately reduced
bleeding rates , albeit less impressively than the combination of adrenaline plus 
,tlirombin (Table 1).
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Gross examination of gastric mucosal tears injected by the various substances 
and removed 1 horn- after injection therapy revealed oedema and blanching but 
no other gross abnormalities . Microscopic appearance was similar in all 
cases(showing oedema and submucosal haemorrhage) other than where fibrin 
sealant was injected . This showed an amoiphous acellular eosinophilic material 
occupying the submucosa at the site of injection . (figure 2,3) In addition in one 
case where a combination of adrenaline and human thrombin were used , an 
area of significant inflammatory reaction , involving large numbers of 
polymorphs was seen within the mucosa , spilling over into the muscularis 
propria . However , as the animal had been killed within one hour of the 
injection , the surprising extent of the inflammation noted raises doubt whether 
this observation was secondary to injection therapy or as part of an incidental 
area of mucosal erosion (figure 4,5) .
(2 )-S em i-a cu te  exp erim en ts
Gross examination of the stomach removed 60 hours after injection with 
adrenaline plus thrombin revealed no major gross changes . Microscopic 
examination showed submucosal haemorrhage , dilated veins with thrombosis 
and local necrosis of walls . However no significant changes in the arteries 
were seen.
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Figures 2&3 Experimental ulcer injected with fibrin sealant 
(Acellular amorphous eosinophilic material occupying the submucosa represents the
injected fibrin sealant)
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Figures 4&5 Experimental ulcer injected with adrenaline plus thrombin
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(3)-Experiments involving peripheral (ear) arteries 
Acute changes(2 hour after injection)
Adrenaline , fibrinogen , 50% dextrose , 98% alcohol and a mixture of 
adrenaline plus thrombin caused haemorrhage around the central artery, non 
occlusive venous thrombosis but no arterial thrombosis (figure 6,7,8).
Chronic changes(56 hours after injection)
(a)- Adrenaline plus thrombin caused non occlusive venous thrombosis without 
ischaemic necrosis of the overlying skin (figure 9).
(b)-Ethanolamine(5%) caused extensive occlusive venous thrombosis and 
ischaemic necrosis of adjacent skin (figure 10,11).
i
Figure 6 Section of ear injected with adrenaline(showing non occlusive venous thrombosis
but no tissue necrosis)
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Figure 7&8 Section of ear 2 hours after injection with adrenaline plus thrombin(showing 
no arterial thrombosis and no tissue necrosis)
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Figure 9 Section of ear 56 hours after injection with adrenaline plus thrombin(no ischaemic
necrosis occurred)
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Figure lO & ll Section of ear 56 hours after injection with 5% ethanolamine(extensive tissue
necrosis)
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Discussion
In a rabbit model of acute gastric mucosal bleeding , prompt haemostasis was 
effected by injection of adrenaline plus thrombin and by sprayed fibrin sealant. 
Adrenaline injected alone also stopped active bleeding , albeit less conclusively 
than these modalities . Other agents ; thrombin alone , injected fibrin sealant, 
50% dextrose and 5% ethanolamine did not immediately stop bleeding but all 
exerted a modest delayed haemostatic effect. Histological examination of 
injected tissues did not reveal the mechanism by which haemostasis was 
achieved . No agent was shown to cause arterial tlu’ombosis .
Various methods have been employed in the creation of experimental ulcers . 
They include ; mechanical methods (by excision of disk shaped segments of 
mucosa or small mucosal incisions with a scalpel), chemical methods (by 
submucosal injection of 98% ethanol) and the use of “ the ulcer maker “ 
(Rajgopal et al 1992 , Whittle et al 1991 , Protell et al 1978 , Chung et al 1991). 
Unfortunately an appropriate animal model of peptic ulcer bleeding has not been 
developed and the experimental situation of acute mucosal tears is far removed 
from the clinical state of patients presenting to hospital with ulcer haemorrhage . 
The rabbit stomach was chosen because it is an animal with gastric anatomy and 
physiology similar to that of man (Wara et al 1957) and an animal successfiilly 
used by others in ulcer bleeding experiments (Rajgopal et al 1991 , Wara et al 
1957 , Dilley et al 1995 , Kivilaakso et al 1981).
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Nevertheless , the experiments described in this study do suggest that an 
adrenaline/thrombin combination might be appropriate for active bleeding . The 
efficacy of this mixture contrasts with the relatively poor haemostatic efficacy of 
ethanolamine , 50% dextrose and thi'ombin injected alone . Thus , adrenaline is 
the most effective drug for treating active bleeding but its temporary 
vasoconstricting activity might be expected to be associated with rebleeding . 
The combination with an agent (such as thrombin) which may cause thrombosis 
is therefore logical . The failure of thrombin (or any other agent) to tlnombose 
arteries may be a defect of the experimental model since one would only expect 
arterial thrombosis to occur if the injection is directed into the arterial lumen . 
hi clinical practice , endoscopists may attempt an intra-arterial injection into the 
bleeding artery , whilst this was not possible in my experimental m odel.
The injected substances produced a range of macroscopic and histological 
effects . These were relatively mild following adrenaline and thrombin , but 
considerable delayed necrosis was associated with 5% ethanolamine injections . 
hi addition , its relative ineffectiveness in stopping mucosal bleeding suggest 
that sclerosants may not be optimal agents for treating ulcer bleeding in man . 
This conclusion is reinforced by case reports of major complications following 
their use in clinical practice (Meissner et al 1993 , Farrell et al 1993 , Goldberg 
et al 1993 , Loperfids et al 1990 , Pousset et al 1992 , Roul et al 1991 , Levy et 
al 1991 , Lumen et al 1994). hi contrast adrenaline and thrombin injection have
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not been associated with complications in clinical pracice . The use of 
adrenaline is now established in clinical practice(Choudari et al 1994 , Chung et 
al 1988 , Villanueva et al 1993 , Chung et al 1993) ; that of thrombin is 
controversial and is worthy of further study .
hi these experiments sprayed fibrin sealant proved to be an effective 
haemostatic agent and may be worthy of further study . Unfortunately, and in 
contrast to injected agents , sprays are difficult to use in clinical practice , 
although a combination of adrenaline injection(to stop active bleeding) followed 
by a fibrin spray(to stimulate thrombosis within the bleeding vessel or to form a 
plug which scales the hole in the bleeding vessel) could represent a viable 
approach.
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Chapter 3
Endoscopic injection for bleeding peptic ulcer : a comparison  
of Adrenaline alone w ith Adrenaline plus hum an Thrombin
81
Introduction
The prognosis of patients who present to hospital because of major peptic 
ulcer haemorrhage is improved by endoscopic injection therapy . A range of 
solutions have been injected and all have similar efficacy in reducing the rate 
of rebleeding , operation and mortality (Panes et al 1987 , Lazo et al 1992 , 
Balanzo et al 1988 , Rajgopal et al 1991) . hi controlled trials , Choudari et al 
(1994) and Chung et al (1993) showed that diluted adrenaline (1 : 100,000 or 1 
: 10,000 ) is at least as effective as alternative regimes and in contrast to 
sclerosants injections (Loperfido et al 1990 , Pousset et al 1992 , Roul et al
1991 , Levy et al 1991) , adrenaline has not been associated with systemic or 
local complications .
Unfortunately 15-20% of patients continue to bleed despite technically 
successful injection therapy (Panes et al 1987 , Lazo et al 1992 , Balanzo et al 
1988 , Rajgopal et al 1991 ,Lin et al 1993) , This may be because the bleeding 
artery is not tlri’ombosed ; indeed experiments in animals fail to show arterial 
thrombosis following adrenaline injection (Rajgopal et al 1992 , Chung*et al 
1988 , Rutgeerts*et al 1989 ) .
Bovine thrombin has been injected into gastro-duodenal bleeding lesions to 
stop bleeding and prevent rebleeding (Juszkiewicz et al 1993 , Moreto et al
1992 , Balanzo et al 1990 , Benedetti et al 1991 , Koyama et al 1995 ) . 
Although the use of thrombin is attractive because it represents the best 
theoretical approach to causing thrombosis , trials have not shown that this is 
better than injection using alternative injection solutions(Balanzo et al 1990 , 
Benedetti et al 1991 , Koyama et al 1995) . This may be because studies have 
involved small numbers of patients , a suboptimal dose of tlnombin , 
inappropriate patient selection and because some high risk patients have been 
excluded.
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Since the results of my own experimental studies demonstrated that a 
combination of adrenaline plus thrombin may be the most potent modality in 
inducing haemostasis , in this study I have examined the efficacy of a 
combination of adrenaline plus thrombin extracted from pooled human plasma 
as injection therapy for bleeding peptic ulcer, comparing it with 1 : 100,000 
adrenaline injections . As shown to in the introduction (Chung^ et al 1988 & 
Rajgopal et al 1991 ) ,  the clinical efficacy of endoscopic haemostatic therapy 
using 1:100,000 and 1: 10,000 adrenaline are similar .
!
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Patients and Methods 
Design and Inclusion Criteria
Between October 1994 and November 1995 , consecutive patients presenting 
with severe gastrointestinal haemorrhage were considered for this study. 
These patients were admitted to the foui' acute receiving units in the Lothian 
region of Scotland (Western General Hospital, Edinburgh, Edinburgh Royal 
Infirmary, St John's Hospital, Livingston and the Eastern General Hospital, 
Edinburgh). The admitting teams then contacted me , using an air call pager . 
After resuscitation endoscopy was perfonned in all cases by myself* using an 
Olympus XQIO forward viewing gastroscope . Patients who were found to 
have a peptic ulcer that was either actively bleeding or had a non bleeding 
visible vessel were included in the study if they had one other clinical risk 
factor . These risk factors were age over 60 years , initial haemoglobin 
concentration of less than 10 g/dl or shock, defined as a pulse rate greater 
than 100 beats/min or a systolic blood pressure less than 100 mm H g , or both 
. A history of non steroidal anti-inflammatory drug (NSATD) use , previous 
history of peptic ulcer disease and Helicobacter pylori status were recorded . 
Patients who were admitted to hospital because of peptic ulcer haemorrhage 
(primary bleeders) and patients who bled after admission for other medical 
conditions(secondary bleeders)were recruited .Comorbidity was assessed in 
each patient.
1 had done 500 upper GI endoscopies while working as SHO in General surgery as part o f  
my basic surgical training, some were therapeutic procedures . Furthermore, 1 received 
mtensive training by D r KR Palmer in August and September 1994 during which a further 200 
endoscopies were carried out by myself.
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Cardiovascular morbidity was defined as previous myocardial infarction with 
recurrent angina attacks and/or the presence of congestive cardiac failure . 
Respiratory comorbidity was defined as the presence of chronic obstructive 
airways disease sufficient to limit normal daily activity and or pneumonia at 
the time of bleeding . Renal comorbidity comprised chronic elevation of 
serum creatinine to greater than 500 mM/1, Neurological disability was 
defined as central nervous system disease resulting in loss of physical 
independence ; it encompasses clironic disability due to stroke , demylinatlon 
or other degenerative neurological disease . Post operative phase was defined 
as the period in which a patient was in hospital after a major operative 
procedure . Mental and physical handicapped individuals were those 
institutionalised for cerebro-vascular disease or cerebral palsy .
Over the study period 289 patients were endoscoped and 149 were excluded , 
because they had bled from other causes(n=91), did not have major stigmata 
of recent haemorrhage within an ulcer bed(n=55), had significant liver 
disease(l patient) or were receiving anticoagulant drugs(2 patients).
Patients were randomised by opening a sealed envelope to receive either 
injection with dilute adrenaline (group 1) or adrenaline plus human thrombin 
(group 2) *. The randomisation was carried out during the endoscopy, after 
examination of the peptic ulcer, before injection of dilute adrenaline . In 
many cases it was necessary to wash the ulcer bed using endoscopically 
positioned catheters in order to demonstrate major stigmata of haemorrhage. 
Informed Consent :
This study was given ethical permission by the Medicine&Oncology ethical 
subcommittee of the Lothian Healthboard . Wlien possible informed written 
consent was obtained from each patient or a relative prior to endoscopy . It 
was recognised by the subcommittee and myself that this is nevertheless not 
truly informed since an acutely ill patient or the relatives are not in a position 
to electively consider the implications of trial participation .
______________________
Endoscopic technique
Injections were administered using a disposable 4mm , 23 gauge injection 
needle (Keymed L td , Southend upon sea , U K ). Group 1 were treated with 
multiple injections (each 1-2 ml) of 1 ; 100,000 adrenaline into and around the 
bleeding vessel. Group 2 patients were injected with 1 : 100,000 adrenaline in 
exactly the same manner followed by at least 2.8 ml (600 lU) injection of 
human thrombin injected into the vessel.
Human thrombin used in this trial was manufactured from pooled human 
plasma and was donated on a named patient basis (as a component of a fibrin 
sealant kit ) by the Scottish National Blood Transfusion Service .
The volume of injection was similar in groups 1 and 2 . Group 1 patients 
received 4-18 mls(median 10 mis) of 1:100,000 adrenaline . Group 2 patients 
received 4-12 mis (median 7 mis) adrenaline, plus 2.8-4.5mls(median 3.5mls) 
of thrombin suspended in 40 mM calcium chloride , representing 600-1000 lU 
of human thrombin (I intentionally aimed to give those receiving combinaikm therapy 
smaller volume o f adrenaline. The volume o f  adrenaline injected depended on the size o f  
ulcer , the control o f  bleeding and the patient's tolerance o f the endoscopic procedure) . This 
dose of thrombin is similar to that which has been shown to reduce blood loss 
when injected into anastamosis during vascular surgery(Milne et al 
1995&1996).
Management following endoscopy was left in the hands of the admitting teams
who were unaware of what was injected. The success or otherwise of the 
endoscopic therapy was communicated to these doctors .
Decision regarding blood transfusion and need for emergency surgery were 
made independently by those teams .
II
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End points
The following endpoints were determined :
(1)-Re-bleeding , defined as fresh haematemesis or melaena , or both with 
either shock (pulse rate greater than 100 beat /min and systolic blood pressure 
less than 100 mm Hg) or a fall of haemoglobin concentration of at least 2 g/dl 
over a 24 hour period . Re-bleeding was in every case confirmed by endoscopy 
or emergency surgery.
(2)-Surgical operation . Re-bleeding was the only indication for surgery .
(3)-Units of blood transfused .
(4)“Duration of hospital stay
(5)-Thii1y day mortality (from the time of admission).
Repeat Endoscopy
This was performed in one of these situations
(1)-lf in my opinion of , the initial endoscopic injection was felt to be 
suboptimal ; because blood made therapy difficult or because of an awkuad 
ulcer position .Repeat endoscopy was then undertaken within 24 hours as a 
plamied elective procedure .
(2)-To confirm rebleeding
(3)-At the request of admitting teams if there was doubt concerning rebleeding 
Policy after re-bleeding
Re-bleeding was treated either by surgical operation or by endoscopic therapy 
(if requested by the admitting team ). Endoscopically treated re-bleeding 
patients received the same form of endoscopic therapy as was given at the time 
of admission .
Statistical Analysis
Differences in rebleeding and mortality rates were analysed using the chi 
square test and Fisher's Exact test respectively . Differences in blood 
transfusion was carried out using the (t) te s t.
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Results
One hundred and forty patients fulfilled the inclusion criteria and were 
randomised Two patients (one in each group) in whom initial treatment was 
thought by myself to be suboptimal had elective repeat endoscopic 
therapy(using the same injection materials) within 36 hours . Both patients 
presented with active bleeding and although initial haemostasis was effected in 
both cases , anatomical distortion and the presence of blood resulted in 
uncertainty about the adequacy of the procedure .
Table 1 shows the characteristics of the randomised patients , The two groups 
were well matched with regard to age , sex , NSAID intake , ulcer type and 
risk factors for re-bleeding (admission haemoglobin concentration, shock , 
serious co-morbid disease and endoscopic stigmata).
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The nature of comorbid diseases is shown in table 2 .
Table 3 shows outcome in the two groups . Fourteen group 1 patients (20%) 
and thi’ee group 2 patients (4.5%) rebled during their hospital admission 
(p<0.G05). Those who rebled included significantly greater number of patients 
who presented with active bleeding than those who at endoscopy had a non 
bleeding visible vessel (11 versus 6) (p<0.036). Ten group 1 patients who 
rebled were re treated with adrenaline alone and permanent haemostasis was 
achieved in five . Permanent haemostasis was not achieved by endoscopic 
therapy in seven gi'oup 1 patients. Five of these underwent urgent surgery, 
one died fiom exsanguination before a surgical operation could be performed 
and a further patient who was imfit for surgery because of a recent myocardial 
infarction had no further bleeding following an intravenous infiision of 
octreotide .
A total of eight patients from groups 1 and 2 who continued to bleed had 
emergency surgery . All but one recovered , although all had serious post 
operative complications . One patient died six days after emergency surgery of 
adult respiratory distress syndrome .
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Table 2 rType and distribution of co morbid disease
Group 1(45} GrouQ_2(3BJ
Cardiovascular 9 6
Respiratory 6 5
CardiovascuIar& 1 3 1 5
Respiratory
Cardiovascular
Respiratory&Renai 2 4
Neurological 3 1
Renal ^  2 1
Post-operative 6 4
Mental&physicai 4 2
handicap
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Although median transfusion requirements were similar in both groups , 
significantly more total units were transfused in group 1 compared to group 2 
(297 versus 219 , p<0.041) . The dur ation of hospital stay was similar in both 
groups .
Seven group 1 patients died but there were no fatalities among group 2 patients 
(p<0.013). Deaths were restricted to patients who had severe comorbid 
disease , and three of these occurred in secondary bleeders who had been 
admitted to hospital because of umelated serious medical problems . One of 
these died from bleeding which occurred in association with multiple 
complications associated with total cystectomy for invasive transitional cell 
carcinoma . A_second patient suffering from congestive cardiac failure due to 
ischaemic heart disease rebled and died in congestive heart failure . A third 
patients died from recurrent bleeding in association with chronic renal failure 
and disseminated intravascular coagulation . A fourth elderly patients was 
admitted because of upper gastrointestinal bleeding in association with lobar 
pneumonia and died seven days later of respiratory failure despite successful 
treatment of her bleeding ulcer . A fifth patient had imsuccessftil injection 
therapy for bleeding ulcer followed by two laparotomies for gangrenous 
appendicitis and septicaemia . One other death followed emergency ulcer 
surgery . A final patient exsanguinated from ulcer bleeding before an operation 
could be_performed.
No complications followed endoscopic therapy in either group . The presence 
of Helicobacter pylori on biopsies did not influence outcome .
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Discussion
In this tiial of patients presenting with major peptic ulcer haemon'hage, combination 
injection treatment with dilute adienaline plus human thrombin acliieved significantly greater 
permanent haemostasis and improved mortality compared to patients treated by adrenaline 
alone.
Previous studies had shown that conservatively managed patients who have major endoscopic 
stigmata of bleeding have a high risk of uncontr olled bleeding and rebleeding (Chang-Chin et 
al 1988, Breariy et al 1985 , Bornman et al 1985 , Clason et al 1986). Others have shown 
that tills risk is greatly reduced by endoscopic therapy (Panes et al 1987 , Lazo et al 1992 , 
Balanzo et al 1988 , Rajgopal et al 1991). Consequently I felt it imetliical to include a control 
( no endoscopic treatment arm) in die cmrent study.
All patients who died had significant medical comorbidity and thr ee deaths occurred in 
patients who bled following admission to hospital for illness unrelated to peptic ulcer . It is 
clearly possible that these patients would have inevitably died as a consequence of their 
car diorespiratory or other diseases, that bleeding ulcer was an agonal hicidental event and by 
chance all of these were randomised to group 1 . It is likely however that uncontrolled 
bleeding in each case contributed to decompensation of comorbid illness and was an 
important contributor to death. If the deaths in group I which were not directly due to 
exsanguination are excluded, the mortality difference between tlie two groups become non 
significant. However because the analysis was based upon “intention to treat” and because it 
is likely that rebleeding contributed to death by excacerbating comorbid disease, such 
exclusions are inappropriate.
In this study the severity of comorbid disease was not quantified ; nevertheless the definition 
of comorbidity was such that tliese patients had severe illness with significant physical 
disability . The distribution of comorbid disease, including the presence of multiple 
conditions was very similar- in the two groups and differences in outcome following 
endoscopic therapy are luilikely to have been due to unequal distribution of severity or 
number of these.
Although permanent haemostasis was achieved more often with combination therapy than by 
injection of dilute adr enaline alone, the median blood
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transfusion requirements and median duration of hospital stay were similar in 
the two groups .
The length of hospital stay is frequently dependent upon social factors and the 
course of umelated medical illness and it is therefore not surprising that 
duration of hospital stay was similar in the two groups . The observation that 
total transfusion requirements was less in group 2 , yet ruedian transfiised units 
was similar in both groups reflects the wide range of transfusion necessary in 
this study.
Lin et al (1993) showed in clinical trial that haeiuostasis from bleeding ulcer 
can be as readily achieved by injection of inert substances as by injection of 
sclerosants and adrenaline . This suggested that a "tamponade effect" in which 
a relatively large volume of fluid injected into the rigid confines of a chronic 
ulcer , can stop bleeding by compressing the bleeding vessel. Others(Leung et 
al 1987 , Chung*et al 1988 , Lai et al 1994) have also referred to this possible 
mechanism . hi the current study the median total injected volume was siiuilar 
in the two groups . Therefore although a "tamponade effect" may have 
contributed to haemostasis in many patients , I have demonstrated an 
additional specific effect for human thrombin .
The efficacy of injected bovine thr ombin (alone or in combination with other 
agents) has been examined in several clinical trials with varying conclusions . 
Juszkiewicz et al (1993) randomised 50 patients who presented with non­
bleeding visible vessels within peptic ulcers to either no endoscopic therapy or 
injection with 200 lU of "animal thrombin" and reported a rebleeding rate of 
4% in the treated group compared to 40% in the control group . Wliilst this 
difference is statistically significant(p<0.01) and encouraging , there must be 
reservations about the conclusions of such a small study . This criticism also 
applies to the trial reported by Moreto et al (1992) who randomised 38 
patients(with spurting , oozing or non bleeding visible vessel) to conservative 
therapy or injection with ethanolamine plus 50 lU of bovine tlnombin . Re-
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bleeding in the treated group was 5.3% compared to 57.9% in the control 
gmup .
The clinical trial which is most comparable to my own is that reported by 
Balanzo et al (1990) who randomised 64 patients who had been admitted to 
hospital because of ulcer bleeding and were found at endoscopy to have active 
bleeding or a non bleeding visible vessel to adrenaline alone(l : 10,000) or 
adrenaline plus 150-300 lU of bovine tlirombin . Re-bleeding rates (18.7% vs 
15.6%) and other end points in both groups were very similar . It is likely that 
this trial eliminated some high risk cases since patients aged over 80 years and |
those unable to give written consents were excluded . The number of patients 
included was less than in our study and the amount of injected thi'ombin was 
approximately 25% of that used by ourselves . Other_studies of thrombin are 
not comparable with the current study and do not clarify the value of thrombin 
. For example , Koyama et al (1995) reported a trial involving 62 patients who 
were found to have a non bleeding visible vessel within a gastric ulcer . All 
ulcers were sprayed with a mixture of dilute adrenaline plus 20,000 lU of 
"thrombin" and half were randomised to absolute alcohol injection . Perhaps 
not surprisingly the injected group had a lower rebleeding rate tharrthe group 
who were not injected(12 versus 34.5%).
Benedetti et al (1991) studied 82 patients injected with either 1% polidocanol |
S'(28 patients) or 100 lU of bovine thrombin (54 patients). They excluded
patients with "giant ulcers covered by a large blood clots", those with firm
sclerotic ulcers and those with deep ulcers. The remaining patients had ulcers I
which were either active bleeding , had a non bleeding visible vessel, were
oozing or had an adherent c lo t. Rebleeding rate was similar in both groups
(17.8% vs 14.8% respectively) .
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Other trials have compared the efficacy of adrenaline injection with that of 
adrenaline in combination witli sclerosants (Choudari et al 1994 , Chung et al 
1993 , Villaneuva et al 1993) . These studies do not show advantages for 
combination therapy using either ethanolamine(Choudari) , sodiimi tetradecyle 
sulphate (Chung) or polidocanol(Villaneuva) with almost identical rates of 
uncontrolled bleeding , rebleeding , surgical inteivention and death . The 
approach to haemostasis of injection plus a thermal modality is theoretically 
attractive and many clinicians use combination injection with bipolar 
electrocautery, heater probe or less frequently Laser photocoagulation 
although these approaches have only been evaluated in a small number of 
patients (Loizou et al 1991). Trials are necessary to compare these options and 
a comparison of adrenaline plus thrombin versus adrenaline plus a thermal 
modality has m erit.
The current study clarifies the value of adrenaline plus tlnombin injection 
therapy in patients who exhibit major stigmata of haemorrhage . Unlike many 
previous studies , the highest risk patients were not excluded , an adequate 
sample size was studied and endoscopic therapy was undertaken by a single 
endoscopist using a standard technique and a relatively high dose of human 
thr ombin . The injected dose of human thrombin used in the current study was 
at least 60% greater than that employed in other clmical trials of bleeding 
peptic ulcer . This dose of human thr ombin was chosen because of experience 
in vascular sirrgery . When injected in combination with fibrinogen as a fibrin 
sealant, 600-1000 lU thrombin significantly reduced bleeding fiom 
anastomosis fashioned during carotid endarterectomy (Milne et al 1995) and 
peripheral vascular surgery (Milne et al 1996). Furthermore although no 
formal , sequential studies of intravascular thrombosis have been undertaken 
in these trials neither local nor systemic thrombosis nor embolisation have 
occurred .
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It is possible that both bovine and human thrombin could provoke anaphylactic 
reaction , particularly in repeated injection are administered . However such 
reactions have not been reported despite relatively extensive use of thrombin 
in vascular surgery (Milne et al 1995&1996 , Kram et al 1988) , as well as 
therapy for gastric and oesophageal varices () and in the current and other trials 
of peptic ulcer bleeding .
The thrombin used in this trial was manufactured from pooled human plasma . 
The extraction procedure includes a solvent-detergent virus step which has a 
good safety record (Bemiet et al 1993). hi addition this product has been used 
as part of fibrin sealant in a number of clinical trials and no evidence of virus 
transmission was found over a six month serological follow up period (Mine et 
al 1995 , Bemiet et al 1993)),
Recombinant thrombin is currently being manufactured by the Scottish Blood 
Transfusion Service and concerns relating to viral transmission are therefore 
likely to be completely eliminated in the near future .
The current study encourages us to believe that injection with a combination of 
dilute adrenaline plus human tlnombin is a significant therapeutic advance in 
the management of major peptic ulcer bleeding . This conclusion must be 
confirmed by larger studies and issues of toxicity relating to possible 
tlnombotic complications and viral transmission must be addressed .
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Chapter 4
The outcome of urgent surgery for major Peptic Ulcer Haemorrhage
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Introduction
The management of major peptic ulcer haemorrhage has been transformed 
by therapeutic endoscopy . In most centres injection or thermal methods of 
haemostasis are applied to actively bleeding ulcers and to ulcers which 
contain a visible vessel . These approaches usually stop active bleeding and 
prevent rebleeding (Panes et al 1987 , Swain*^ et al 1986 , Chung et al 
1989 , Liane 1987), but are not always successful and patients who 
continue to bleed require urgent surgical inteivention .
The choice of surgical operation for bleeding ulcer is controversial. Some 
centres favour a relatively aggressive siu’gical approach including vagotomy 
and pyloroplasty , ulcer excision or partial gastrectomy rather than 
underrunning the bleeding vessel alone . This is supported by series 
reporting better outcome following definitive surgeiy (Humphrey 1982 , 
Dronfield et al 1979 , Poxon et al 1991).
Poxon and colleagues reported a multicerntre randomised prospective trial 
comparing minimal surgery(under-ruiming or ulcer excision and adjutant 
intravenous Ranitidine) with conventional ulcer surgery(vagotomy and 
pyloroplasty or partial gastrectomy) for the treatment of peptic ulcer 
haemorrhage . One hundred and twenty nine patients were randomised to 
conservative therapy(n=62) or conventional surgery(n=67) . Twenty nine 
patients died , 16(26%) after conservative surgery and 13(19%) after 
conventional surgery . The only significant difference between the two 
groups was the incidence of fatal rebleeding , which occuired in six
100
patients after conservative surgery compared with none after conventional 
surgery (p<0.02).
Dronfield and colleagues retrospectively compared the outcome of patients 
undergoing ulcer surgery in two hospital in Nottingham . They reported that 
for bleeding gastric ulcers , partial gastrectomy was associated with 21% 
mortality compared to 50% mortality after conseivative surgery(oversewing 
, local excision with or without vagotomy and pyloroplasty). However the 
role of radical surgery for bleeding duodenal ulcers was questionable in this 
study(mortality following vagotomy and drainage was 12% compared to 
44% after partial gastrectomy). This study could be critised in being 
retrospective . Furthermore only 3 out of 110 patients had under-running 
alone . Humphrey reviewed the surgical literature and concluded in an 
authoritative surgical textbook that undersewing is an inadequate treatment 
which frequently led to récurrent haemorrhage .
Others argue for a minimalist surgical approach because major surgery is 
associated with high morbidity and mortality . Powerful drug therapy 
eliminates gastric acid output and helicobacter pylori infection and previous 
studies reported better outcome in patients treated by underrumiing and 
drug therapy (Rogers et al 1988 , Hunt et al 1979). Rogers and colleagues 
reported the outcome of 61 patients who underwent surgery for bleeding 
gastric ulcers at Glasgow’s Western hifrrmary . Surgery included partial 
gastrectorny(n= 19) , under-sewing plus vagotomy and pyloroplasty(n=20) 
and under-running alone(n=20). All groups were similar in terms of age ,
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severity of haemorrhage , delay before surgeiy and grade of surgeon 
performing the procedure . Mortality in the three groups was 26 , 45 and 10 
per cent respectively.
hi this study I report the Edinburgh experience of patients who undeiwent 
urgent surgical intervention following failure of endoscopic therapy for 
bleeding peptic ulcers between 1990-1995 .
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Patients and Methods
Between June 1990 and December 1995 , 1142 patients were referred for 
urgent upper gastrointestinal endoscopy because of upper gastrointestinal 
haemorrhage and of these 492 patients(333 men and 159 woman) with 
significant peptic ulcer haemorrhage were considered for inclusion in 
clinical trials . These patients were admitted to the four acute receiving 
units in the Lothian region of Scotland( Western General Hospital, Royal 
Infirmary/Edinburgh , Eastern General Hospital and St. John’s Hospital at 
Howden ) .  They were referred to myself or 2 previous research fellows 
from the Western General Hospital for endoscopic therapy(inj ection or 
heater probe therapy). Patients had peptic ulcers which were actively 
bleeding or had a non bleeding visible vessel. hi addition , patients had one 
other clinical risk factor . These risk factors were age over 60 years , initial 
haemoglobin concentration of less than 10 g/dl or shock , defined as a 
pulse rate of greater than 100 beats/min or a systolic blood pressur e less 
than 100mm Hg , or both . A history of non steroidal anti-inflammatory 
drug (NSAID) use and evidence of serious co morbid disease were 
documented .
Of these patients , 67(13.6%) patients had emergency surgery due to 
torrential bleeding which made accurate diagnosis and endoscopic therapy 
impossible(n=9), continuous uncontrolled active bleeding(n-5) or 
rebleeding (n-53) following endoscopic therapy . These surgical operations
103
were carried out by different surgeons in four hospitals . None had a 
specific policy as to the type of operation which should be performed .
The clinical characteristics of these patients , the type of surgery undertaken 
and outcome in terms of rebleeding and mortality were compared . This was 
done by examining completed audit forms , case notes and individual 
follow up by the three research fellows . I compared the gr oup of patients 
receiving conservative therapy(underrunning alone)(n=28) with those 
receiving other operations (underrunning plus vagotomy&pyloroplasty 
(n=24), excision alone (n=3) , excision plus vagotomy&drainage (n=3) and 
partial gastrectomy/antrectomy(n=9).
Statistical analysis
Comparison between the study groups was carried out using the chi square 
test and results considered significant for p<0.05 .
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Results
Table 1 shows the characteristics of the study groups and the type of 
operation carried ou t. The two groups were well matched for age , sex , 
non steroidal anti-inflammatory drugs intake and ulcer type . In addition, 
the severity of bleeding (haemoglobin concentration , presence of shock and 
proportion of patients with serious comorbid disease) were similar .
Twenty eight patients underwent conservative surgical therapy defined as 
underrunning of the ulcer without a further surgical procedure (group 1). 
Thirty nine patients underwent radical operative intervention ; 24 had 
underrunning with vagotomy & pyloroplasty(V&P) , 3 had ulcer excision ,
3 had excision plus V&P and 9 had partial gastrectomy / antrectomy (group 
2).
Table 2 shows outcome in the two groups in terms of rebleeding and death . 
Seven(25%) group 1 patients rebled after conservative surgery . One 
patient(2.5%) from group 2 (the radical group) had further bleeding 
(p<0.015). There were 7(25%) post operative deaths in group 1 patients 
and 5(12.8%) deaths in group 2 (NS/ p=0.2). The overall post operative 
mortality was 18% .
The ratio of consultant to non consultants performing these operations was 
(18/10) in group 1 and (25/14) in group 2 ,
Twenty nine (8.7%) men and 38(23.8%) women underwent urgent surgery 
after failed endoscopic therapy (p<0.0001).
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Discussion
Rebleeding and hospital post operative mortality were higher in patients 
treated by simple undermnning of the bleeding ulcer than in those treated by 
more radical surgery .This finding was not due to differences in case mix . 
Risk factors for rebleeding and death, particularly age , admission 
haemoglobin concentration , the presence of shock and severe comorbid 
medical diseases were very similar in the patient groups . Thus , poor 
outcome in conservatively treated patients was not attributable to a greater 
need to perform a rapid , simpler operation because of differences in 
bleeding severity and comorbid illnesses . It is worthy of note that there was a 
greater number of gastric ulcers treated by radical surgery than by underrunning 
alone(46% vs 30%) . This did not achieve statistical significance (p=0.32 ). 
Outcome was not influenced by seniority of the surgeon since the proportion 
of operations performed by consultants and non consultants was similar . 
The specialist interest of the general surgeons involved was not recorded , It is 
possible that those with interest in Gastroenterology would obtain better results but 
we have no evidence to support this possibility .
It is not clear why more radical surgery proved more effective than simple 
underrunning in this series . However my findings reflect those of Dronfield 
et al(1979) and Poxon et al(1991) who also reported a trend toward better 
outcome with an aggressive surgical approach . Whilst one can understand 
that partial gastrectomy or excision which remove the bleeding ulcer 
effectively prevent rebleeding , one has difficulty with the observation that 
vagotomy and pyloroplasty with underrunning proved superior to 
underrunning alone . All patients received powerful ulcer healing drugs 
before and after surgery and if acid plays any role in ulcer bleeding , it is
107
 : : :    '     ... ... .....
surprising that conservatively treated patients faired relatively poorly . 
Perhaps the anatomical aspects of pyloroplasty are important, since these 
could influence the vascular supply of the duodenum , and may allow 
greater surgical access to the bleeding lesion compared with a small 
duodenotomy.
Most patients undergoing surgery in this series had been subjected to 
endoscopic injection or heater probe therapy ; in a minority torrential 
bleeding or failure of access prevented th is . It is possible that endoscopic 
therapy influences the outcome of surgery. Local oedema commonly 
occurs at injection sites , but this did not apparently increase the difficulty 
of the surgical operation . Nevertheless , it is possible that this could have 
made undersewing less effective . My policy has been to avoid sclerosant 
injections which can cause local necrosis (Laperfido et al 1990 , Pousset et 
al 1992) , and are more likely to exacerbate the difficulties of surgeiy. 
Only a minority (5.8%) of patients admitted to hospital because of non 
variceal bleeding failed to respond to conseiwative medical or endoscopic 
therapy and required a surgical operation . This may reflect the efficacy of 
endoscopic treatment, particularly as the patients in this study were a 
selective high risk group since they had stigmata of recent haemorrhage . 
Patients without these endoscopic findings invariably have a good 
prognosis and only rarely require surgical intervention (Clason et al 1986 , 
Chang-Chen et al 1988 , Kohler et al 1993) . One potential problem of 
endoscopic therapy is that patients who fail to respond could be put at
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increased risk of death following abortive endoscopic treatment. Patients 
who fail endoscopic therapy undergo delayed surgical operation , which 
may be less successful than early surgery , receive more blood transfusion 
and are more prone to prolonged and repeated hypotensive episodes than 
patients who undergo an early operation (Morris et al 1984 , Hunt 1987) . 
This study reassures us that these potential problems do not apparently lead 
to excessive mortality . In this series overall post operative mortality was 
18% and this compares favourably with that reported elsewhere (Welch et 
al 1986 , Park et al 1994 , Schein et al 1989) .
Our finding that the outcome of females with major peptic ulcer 
haemorrhage is poorer than males was an unexpected incidental finding . It 
could be because the median age of female patients is higher than males (73 
versus 69 years) or because of greater use of NSAID among women (72% 
versus 43.6%). This trend was also noted by Rockhall et al (1995) who 
reviewed 4185 patients with upper gastrointestinal haemorrhage and found 
that both the overall mortality and the age standardised mortality was higher 
in women compared to men .
The type of surgery performed will ultimately depend on several factors ; 
the location and chronicity of the ulcer , the haemodynamic and 
cardiorespiratoiy state of the patient after initial resuscitation and the 
experience and skills of the surgeons available . Effective emergency ulcer 
surgery must be tailored to the individual patient and their pathology but
109
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our findings suggest that a conservative surgical operation is a less effective 
option than a more radical approach .
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Chapter 5
Reduced long term survival following 
major peptic ulcer haemorrhage
111
ïntrodiiction
The late outcome of patients who are discharged fiom hospital after receiving 
endoscopic therapy for bleeding ulcers is uncertain.
Smart et al (1986) reported that 26% of patients who had bled from gastric 
ulcers died within a four to eight year follow up period , usually from causes 
unrelated to ulcer and that 16% suffered rebleeding episodes,
Rorbaek-Madsen et al (1994) also found that late mortality in bleeding gastric 
ulcer patients is high , most deaths being related to co-morbid disease rather 
than further ulcer complications . Hudson et al (1995) followed up 487 
patients(aged>60) who presented with peptic ulcer bleeding for a mean 
duration of 34 months . This included patients with minor and major bleeding 
and none received endoscopic haemostatic therapy . They reported a mortality 
of 29% in the study group compared to 12% in an aged and sex matched 
controls .These reports concentrated upon survival determined by case notes 
review and death registry check; little is Icnown of prognosis in terms of 
subsequent ulcer symptoms and their relationship to bleeding events and death 
. In this study I have examined late outcome in a series of patients who 
received endoscopic therapy for major peptic ulcer bleeding. The purpose of 
this was to define causes of death and to examine morbidity from further 
bleeding and other ulcer related events.
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Patients and Methods
The study group was recruited from patient cohorts who took part in two 
clinical trials between Dec 1988 and May 1992 . hr the first of these(Rajgopal 
et al 1991) , 109 patients were randomised to endoscopic injection therapy 
with dilute adrenaline and ethanolamine or to conservative management. Fifty 
six of these received endoscopic therapy , two died in hospital and long term 
information from 54 was available . The second clinical trial(Choudari et al 
1992) involved 120 patients who were randomised to endoscopic therapy 
using the heater probe or injection sclerotherapy with a combination of dilute 
adrenaline and ethanolamine . Eighty two of these were treated before May 
1992 and were considered for long term follow up , 5 died in hospital , no 
follow up information was available from 10 patients because their medical 
records could not be traced and long term information was available from the 
remaining 67 .
The study group thus comprised 121 patients . All of these had presented 
either with active bleeding or a non bleeding visible vessel at endoscopy . hi 
addition they had at least one other adverse prognostic factor fi’om age over 60 
years , serum haemoglobin concentration less than 10 g/dl or shock (defined as 
a pulse rate greater than 100 beats/minute or a systolic blood pressure less than 
100 mm Hg).
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Demographic details of the study group and of patients who could not be 
contacted are shown in table 1.
Table 1
Risk factors In patients who were followed up and those who could not be traced
Traced N on-traced 
( 121) ( 10)
64% 70%
Median age(range) years 68(20-96) 68(23-78)
Gastric ulcer 37% 30%
Duodenal ulcer 623 70%
Others l % o%
Active bleeding 53% 60%
Stigmata of recent haemorrhage 4 7 % 40%
Patients on NSAID 37% 20%
Mean haemoglobln(SD) g/dl 8.8(2) 8.5(2.2)
Co-morbid disease 46% 4 0 %
Fifty five patients in the study group had serious co-inorbid disease as defined 
by admitting medical teams.(table 2)
Table 2
Cardiovascular
Respiratory . ^
Neurological ^
Renal ^
Others ^
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Endoscopie therapy was successfrü in 119 patients ; the two remaining patients 
underwent emergency surgery.
As previously reported , the short term outcome of patients treated by injection 
or the heater probe was similar (Choudari et al 1992) .
Follow up
Median length of follow up was 36 months(range 30-76) . Causes of death 
were obtained from hospital records and surviving patients were contacted by 
postal questiomiaires . General practitioners were contacted when information 
was uncertain.
The postal questionnaire addressed the need for frirther hospital admission 
including endoscopy , recurrent bleeding and details of drug therapy . A simple 
dyspepsia questionnaire was used to quantitate indigestion(figure 1) . This 
was validated in 100 outpatients attending for routine upper gastrointestinal 
endoscopy.(table 3)
Table 3 -Validation of 
dyspepsia questionnaire
Dyspepsia score 0-2 3-5 >5
Patients with "positive 5 38 15
findings
Patients with negative 35 2 5
findings
Sensitivity = 91% / Specificity = 83% Confidence intervai(Cl) is 
p<0.0001 between 0.84-0.98
"positive findings refer to 
the presence of ulcer or 
untreated oesophagitis
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Long term outcome in peptic ulcer bleeding Questionnaire
A- Please Tick or put a Circle as appropriate:
1 - After your hospitalisation a t  .............-...................................... i n ------- /........./-
(a)- Have you had any further hospital admissions for any reason?.
YES NO
If the answer is YES , please state the name o f the hospital : ................................... .
(b)-Have you had any further Endoscopy (the telescope test into the stomach) ?.
YES NO
If the answer is YES , please state the month and the year o f the procedure
YES NO
(c)-Have you had further : Vomiting o f blood --------  -------
Passing o f black motions --------  ---------
If the answer is YES to either o f the above two questions , have these episodes been severe enough for you to report them 
to a doctor ?.
Dyspepsia Questionnaire
Do you frequently suffer from:
Not at ail (0) A llttle (l)  A lot (2)
a-Tummy pain_______________________  _______ _______
b- Heart burn   _ _ _ _ _  __________
c- Acid reflux     _ _ _ _ _
d- Nausea____________________________ ______
e- vomiting _ _ _ _ _  _______ _______
B- Please list any symptoms you suffer from which may be related to your condition
C- Can you list your present medications that you have obtained from your GP or the Hospital (please state dose and 
duration)
Can you list any medicines that you felt the need to buy over the counter (that is without prescription)
D- How often did you seek help from your GP regarding this condition over the last year?
Never Occasionally(l-2 times) Frequently(niore than twice)
How often did you attend a Hospital regarding this problem (Number of times over the last year) 
^ ^  J  yeai-
E-How many cigarettes have you smoked in the last week?  / week
F-How much alcohol did you consume over the last week? ________ unit/ week
Statistical analysis
Mortality in the study gi'oup was analysed using the Kaplan-Mieir method , 
comparing survival with that of the age and sex matched Scottish population 
(Scottish Health Statistics 1993) .
Results
Survival
Late mortality is presented as life table analysis in figure 2 . Survival was 
significantly less than that of the matched Scottish population(p<0.01) . Figure 
3 shows that deaths were almost all restricted to patients who had significant 
co-morbid disease at their initial hospital admission for peptic ulcer bleeding 
(p<0.001) . Thirty patients died during the follow up period . The causes of 
death are summarised in table 4 . Five patients had autopsy , 23 died in 
hospital and 7 died at home . Only two patients died from complications of 
peptic ulcer surgery ; one aged 79 years died at home from myocardial 
infarction 30 days after surgery , the other died at the age of 82 from 
pulmonary thromboembolism 26 days after sui'gery.
The median age of patients who died was 79 years(range 52-96) , that of long 
term survivors was 66 years(range 20-92).
Recurrent bleeding
Eight out of the surviving 91 patients (9%) had hospital admissions , because 
of recurrent peptic ulcer bleeding .Only two of these patients were receiving 
maintenance acid suppressing therapy , none had Helicobacter pylori 
eradication and two others were concurrently receiving therapy with non 
steroidal anti-inflaimnatory drugs without ulcer prophylaxis .
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Morbidity
Twenty two patients (24%) had an average of two hospital admissions for 
reasons uni'elated to peptic ulcer disease . The indication for admission 
principally related to cardio-respiratory and cerebro-vascular diseases.
Seventy six patients(84%) replied to my questionnaire , information was only 
available from the case notes and general practitioners in the remaining 15 
survivors .
Sixty tluee patients (83%) scored 0-2 on the dyspepsia questiomiaire (have had 
very little or no symptoms) . Thirty one (50%) of these patients were receiving 
maintenance therapy , (comprising Ranitidine 150mg bd or cimetidine 400 mg 
bd in 84% and Omeprazole 20 mg in the rest) . Nine patients(12%) scored 3-5 
(had moderate symptoms) and Four patients(5%) scored more than 5 (had 
severe symptoms) . Three out of these were taking maintenance acid 
suppression therapy and one of these had also received Helicobacter Pylori 
eradication therapy six months prior to rebleeding ,
118
JCLO
1]_)
Q_
Z5OL_O) co
-S-™
-M Q-
in oCL
QJJZ _c -M LO
CD-W C  O 
C  o  
c6 00 C l _
I  g
oif) c<D
b "
à
—  JZ fO 4-J
-  i
L_D00
Q_ O0000 OCT)
N  Q_
00O- o
vDQ_
O
i n
L_CO O
o
o
00
oCM
- O
ooo oLO O
if)_C-Wco
E
CÔ>
>L_D
00
6 u |a i a j n s  9 6 e q . U 9 0 J 0 ( j
119
SURVIVAL CURVES OF THOSE WITHOUT AND WITH 
CO-MORBID ILLNESS
100
• No co-morbid disease
X2= 27.6
p < 0 .0 0 0 1
Co-morbid disease
1 I I I----------- 1---------- 1-----------1-----------1
10 20 30 40 50 60 70 80
Survival (months)
Table 4
Causes of death of the deceased group
Cause of death
Cardiovascular(total)
myocardial Infarction 
cerebrovascular accident 
congestive cardiac failure 
peripheral vascular disease
pneumonia and chronic 
obstructive airways disease
Malignant(total)
Oral
Leukaemia
Breast
Number(total=30)
20
7
6
5
2
Peptic ulcer
1 2 0
Discussion
This study shows that the duration of survival for patients discharged from 
hospital following endoscopic therapy for major peptic ulcer haemorrhage is 
lower than that of the age and sex matched Scottish population . Deaths are 
due to serious co-morbid disease or complications of emergency operations . 
Post mortem confirmation was available in only a minority of patients . The 
majority of patients died in hospital and I am confident that the cause of death 
was accurately defined .
High late mortality in the series was not surprising because of the high 
prevalence of co-morbid disease in the study group . The presence of 
concomitant diseases is likely to predispose to a more severe presenting 
episode ; for example patients with significant cardiovascular disease may 
withstand a serious haemorrhage poorly and those with an atheromatous 
bleeding artery within the ulcer bed will probably bleed more extensively than 
patients with relatively elastic vessels . Most studies of patients presenting 
with major ulcer bleeding contain a high proportion of patients who have 
serious co-morbid disease (Panes et al 1987 , S w a in * et al 1986 , Chung et al 
1989 , Liane 1987 , Rajgopal et al 1991 , Choudari et al 1992).
There was no evidence that endoscopic therapy contributed to mortality and 
previous studies have shown that successfiil endoscopic haemostatic therapy 
does not impair ulcer healing (Rajgopal C et al 1993) . hi contrast the 
morbidity of emergency surgery is high ; early postoperative complications are 
common and may be fatal (Poxon et al 1991 , Park et al 1994) . hi this study 
two patients died within 30 days of emergency gastric surgery despite being fit 
enough to be discharged from hospital care . Five other patients admitted with 
peptic ulcer bleeding during the course of our studies also died post
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operatively (a post operative mortality of 23.6%) . However this study only 
deals with patients who were discharged from hospital after treatment for 
peptic ulcer haemorrhage and therefore excludes these early post operative 
deaths.
Many patients who present with peptic ulcer bleeding give no history of 
antecedent dyspepsia and it is therefore perhaps not surprising that the 
majority of patients (83%) had very little or no symptoms . Less than half of 
these were receiving maintenance therapy . Recurrent ulcer bleeding was 
uncommon , the rate of rebleeding in this series was lower than that reported 
from other centres (Rorbaek-Madsen et al 1994 , Graham et al 1993 , Egan et 
al 1991) and most patients who rebled had no symptoms of indigestion (Ming 
et al 1990).
Recurrent bleeding was not related to gender , site of ulcer or age , but it is 
worthy of note that the majority of these re-bleeds occurred in patients who 
had not received long term ulcer healing therapy.
Penston et al (1993) suggest that the widespread use of long-term continuos
therapy with H2 antagonists significantly reduces the level of both 
uncomplicated and complicated ulcer disease and others have suggested that 
Helicobacter Pylori eradication should be undertaken following ulcer bleeding 
(Graham et al 1993) .1 found only a low prevalence of rebleeding , but 
because recur rent bleeding in the presence of co-morbid disease represent a 
life thr eatening event and because symptoms do not predict rebleeding , I 
believe it reasonable to recommend long term healing therapy in all patients 
who present with bleeding ulcers until the results of large randomised 
controlled trials comparing long term maintenance with Helicobacter pylori 
eradication(where appropriate) are available.
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Chapter 6
The effect of octreeotide on gastroduodenal blood flow 
measured by Laser Doppler Flowmetrv in rabbits .
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Introduction
Changes in gastroduodenal mucosal blood flow (GDMBF) may play a 
role in the pathogenesis of gastroduodenal ulceration in humans and 
experimental animals (Piaceski et al 1989 , Cherry et al 1986). In 1842 
Curling (1842) observed acute ulceration of the duodenum associated 
with bums . Cushing(1932) described similar findings in patients 
undergoing brain surgery.
Sato et al (1979) induced haemorrhagic shock in rats . They 
demonstrated that disturbed energy metabolism in the gastric mucosa 
associated with a decline in gastric mucosal blood flow(measured by in 
vivo reflectance spectrophotometry) resulted in gastric mucosal 
ulceration . Kamada et al (1982) compared a group of patients who 
suffered gastric ulceration while in hospital because of major burns or 
head injury with eight healthy volunteers. They found a significant 
decrease in gastric mucosal perfiision(measured by reflectance 
spectrophotometry) in the study group and concluded that mucosal 
ischaemia following head injury and burns is the main cause of acute 
gastric ulceration .
It is now clear that septic or hypovolaemic shock with consequent 
impaired blood flow regularly causes gastric ulceration in experimental 
animals (Haijola et al 1966 , Hottenrott et al 1978 , Kivilaakso et al 
1978) .
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Sato et al (1995) found that the administration of indomethacin and 40% 
ethanol solution to dogs and rats results in a decrease in gastric mucosal 
blood flow(measiu'ed by reflectance spectrophotometiy and H2 gas 
clearance respectively) and concluded that decreased GDMBF may also 
play an important role in non steroidal anti-inflammatory drugs and 
alcohol induced gastric mucosal lesions. In contrast portal hypertensive 
gastropathy is an important cause of upper gastrointestinal haemorrhage 
in cirrhotic patients (Taransky et al 1994) and has been shown to be 
associated with increased GDMBF (Panes et al 1992) .
Until recently measurement of GDMBF (based upon reflectance 
spectrophotometry , neutral red clearance and microspheres clearance) 
has been complex and umeliable . Laser Doppler Flowmeter(LDF) is a 
new method of measuring GDMBF . This instrument measures 
microvascular perfusion tlirough tissue usmg the doppler shift(this is the 
fi'equency change that light and other radiation of a wave natur e undergo 
when interacting with objects in motion , such as red blood cells . Since 
velocity = wave frequency x wave length , therefore , when the 
frequency changes the wavelength change as will the quality by which 
we receive the radiation in lights its colour , in soimd its pitch) . The 
instrument consists of 3 components ; a processor containing the laser 
mounted on a 2 mm endoscopic probe , an output section transferring 
information to a computer which processes the data and a display section
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which also contains the controls necessary to operate the 
instrument, (figure 1,2),
Octreotide is a long-acting somatostatin analogue , SMS 201-995 ,
Sando statin , Sandoz Inc , It has the advantage over somastatin in having 
a half life of 90 mmutes compared to 1-3 minutes of somatostatin itself 
Clinical trials performed in the 1980s suggested that intravenous 
inflision of octreotide tended to improve the outcome of patients with 
peptic ulcer haemorrhage (Linberg et al 1980 , Kayasseh et al 1980 , 
Jenkins et al 1992)
Linberg et al fomid that somatostatin was successfiil in stopping bleeding 
fi’om gastric and duodenal ulcers of 8 out of 10 patients with major 
haemorrhage compared to 1 out of 10 when cimetidine alone was used . 
Kayasseh et al randomised 20 patients with major ulcer haemorrhage to 
cimetidine or somatostatin and found that the success rate in stopping 
haemorrhage was 2/10 and 7/10 respectively . Jenkins et al found 
octreotide to be effective in treating 5 patients with ulcer haemorrhage 
who failed to respond to medical treatment and were unfit for surgery . 
However , others have reflited this assertion (see summary of clinical 
trials)(Burrough et al 1993) . The mechanism whereby octreotide might 
stop peptic ulcer bleeding is unclear . Octreotide significantly reduces 
splanchnic blood flow in experimental animals (Jenkins et al 
1985&1985*) and in healthy subjects (Wahern et al 1986). For example
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Cooper et al (1991) showed that octreotide reduced superior mesenteric 
and portal blood flow by 59 and 49% respectively .
The purpose of this study was to assess the effects of octreotide upon 
gastric and duodenal mucosal blood flow (GDMBF) in experimental 
animals using Laser Doppler Flowmetiy .
Summary of trials of somatostatin QJ 
nr.treotide for peptic ulcer haemorrhage
Octreotide more effective 
than control
Aiifhor&Year 
Kayasseh (1980) 
Basile (1984) 
Corragio (1984) 
Magnusson (1985) 
Antonioli (1986) 
Torres (1986) 
Tulassuy (1989)
No effect of octreotide 
compared to control
Nn of patients Author&Year
20
99
60
95
56
60
67
Somerville (1985) 
Basso (1986) 
Saperas (1988) 
Christainsen (1989)
Nn o f patients 
630 
96 
92 
241
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Figure 1 Laser Doppler Flowmeter
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1......................................
Figure 2 T ypical traces w hich  appear in the com puter screen attached to the
LDF
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M ethods
Experiments were carried out in 8 NewZealand white rabbits with a 
median weight of 3.25kg (2.95-3.95 k g ). Intravenous midazolam , (0.5 
mg/kg) and intramuscular fentanyl citrate (0.315 mg/ml) and Fluanison 
(lOmg/ml) 0.22 ml/kg were used to induce anaesthesia . Further 
injections of intravenous midazolam were used as required to maintain 
anaesthesia . All animals received continuous supplementary oxygen 
through a face mask or via an endotracheal tube (size 2) at 6 1/mm . All 
experiments were carried out on an electrically heated pad at body 
temperature . GDMBF was measured using LDF *(Perimed , Jarfalla , 
Sweden) via an endoscopic probe (PF 309 , diameter 1.9 m m ).
The operator (myself) who positioned the LDF probe was blinded to the 
measurement recorded by the LDF . A co-worker (G.Haydon) recorded 
the measurements and analysed the signals yet was blinded to the type 
and concentration of substances injected .
GDMBF was measured in the body and antrum of the stomach and 
duodenum . Systemic haemodynamic changes(HC) were monitored by 
measuring pulse rate at the cardiac apex (beats per minute)and ear lobe 
skin perfusion using LDF . Intragastric pH was measured using 2 
multistix reagent strips (Bayer Diagnostics , Basingstoke , Hampshire , 
UK) at the beginning and end of the procedure .
Animal 1 ; One animal was intubated then ventilated and an upper 
gastrointestinal endoscopy was performed using an Olympus P 10
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paediatric forward viewing gastroscope (Olympus , Keymed , South end 
on sea , U K ). Serial measui'ements of GDMBF were carried out over 30 
minutes . The same animal was extubated and allowed to breathe 
spontaneously tlirough a face mask delivering 6 L of oxygen . Thereafter 
laparotomy tln'ough a 3 cm upper midline incision was carried out and 
an anterior 4 mm diameter gastrostomy was made . The LDF probe was 
introduced tluough the gastrostomy and serial measurements of GDMBF 
were carried out over 30 minutes .
After this experiment, all measurements of GDMBF were carried out 
via gastrostomy.
Animal 2 : GDMBF and HC assessed over 60 minutes .
Animal 3 : GDMBF and HC assessed over 60 minutes while receiving 
intravenous mjections of 1 ml of normal saline (total of 7 ml) .
Animal 4 : GDMBF and HC assessed over 60 minutes before and after 
an intravenous bolus injection of vasopressin (1 mg/kg) of body weight. 
Animals 5,6&7 : GDMBF and HC assessed over 20 minutes before and 
60 minutes after an intravenous bolus injection of octreotide (40 
microgram/kg) of body weight.
Animal 8 : GDMBF and HC assessed over 100 minutes while receiving 
intravenous doses of octreotide of 10 microgram/kg every 20 minutes 
reaching a cumulative dose of 50 microgiam/kg . This was to study a 
dose response relationship .
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The animals were killed at the end of the procedure with an overdose of 
phenobarbitone .
Statistical Analysis
The values for perfusion at each of the different sites were quoted as 
mean +/- standard error of the mean(SEM). Comparison between the 
study group and control were calculated using the Mann-Whitney-U test 
. Significance was established at a level of p<0.05 .
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Blood flow&Pulse in one rabbit receiving saline only
350
300 ?
100 .
Ear
Pulse
Body
Antrum
Duodenum
10 20 40Time{min) 60 70
250
Figure 4
Blood flow&Pulse in one rabbit receiving normal saline
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Results
Table 1 shows that GDMBF in the duodenum , body and antrum of the 
stomach presented in arbitrary units were not significantly different 
whether measurements were obtained endoscopically or at gastrostomy . 
hifusion of saline did not influence mucosal blood flow in the gastric 
body(p-0.29), antrum(p=0.14) and duodenum(p=0.46) and this was well 
maintained over a 60 minutes period (n= 2) . Pulse rate at the cardiac 
apex and skin perfusion were also unchanged (table 2) . (  ^
Table 1
Mean(+/-SE) GDMBF in a single rabbit, measured endoscopically and 
at gastrostomy/UnitsjSE)
Duration o f Mean GDMBF(SE),Units
measurement(min)| Endoscopic Gastrostomy
Body 5 212(4.9) 189(3.1)
Antrum 5 174(2.9) 171(2.4)
Duodenum_______________ 5_________  169(2.1) 129(1.8)
Table 2
Mean GDMBF,Ear perfusion&Pulse rate during a 60 min period of control
in 2 rabbits
Time(min) 0 10 25 40 60
Site
Pulse(bpm) 120 124 120 128 110
Skin(SE) 90(2.8) 100(2.2) I 69(1.2) 60(1.9) ' 63(0.6)*
Body(SE) 194(3.2) 189(4.6) ; 251(6.9) 212(6.3) :212(4.0)**
Antrum(SE) 182(4.8) 145(3.1) 143(3.6) 159(3.9) ! 205(5.8)/'
Duodenum(SE) 222(6.2) 271(6.6) ; 214(10.1) 260(4.8) '264(3.1)/'/'
* ** A
*p=0.29
**p=b.06
^P"0.14AAp-Q 40
-
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Figure 5
Blood flow&Pulse in one rabbit receiving vasopressin
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Blood flow in a single rabbit receiving octreotide at 20 minutes
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Figure 7
Biood flow&Pulse in one rabbit given octreotide at 10 mins
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Intravenous Vasopressin(l mg/kg) caused significant reduction in 
GDMBF associated with bradycardia and decreased skin perflision (table 
3) figure .
A bolus injection of Octreotide(40 microgram/kg) significantly 
decreased GDMBF (n=3) without affecting pulse rate or skin 
perfiision(table 4) C f  ju fis î f ' /  *
Intragastric pH increased horn 2 to 6.5 in all tlnee animals following 
octreotide but not in control animals or in the animal receiving 
vasopressin . A dose relationship for octreotide and GDMBF was 
demonstrated between 10-50 microgram/kg of octreotide (figure^).
Table 3
Mean GDMBF , Ear perfusion & Pulse rate during a 60 min period 
involving bolus injection of Vasopressin(1 mg/kg)
Min after bolus injection of vasopressin 
Time(min) 0 ! 20
140 150Pulse(bpm)
Ear(SE)
GDMBF(U)
Body(SE)
^trum(SE)
^odenum (S E )
*p<0.03
**p<0.02
***p<0.05
15 25 40
35 45 60
80 50^ 120
53(2.46) ' 24(0.77)^^ 60(3.17)
62(7.37)* ■ 33(1.97) 27(2.16)
44(3.66)** i 17(1.2) 76(8.3)
27(1.8)*** i 80(2.9) 16(0.78)
^p<0.005
:^'^p<0.02
Table 4
Mean GDMBF,Ear perfusion&Pulse rate in 3 rabbits over 
60 mins after a bolus injection of octreotide(40 microgram/kg)
Site
Time(min) 0 10 25 40 60
Ear(SE) 70(2.1) 68(0.8) 63(0.6) 53(1.2) 60(1.1)*
Pulse(bpm) 124 120 130 120 120
Body(SE) 178(3.1) 126(2.2) 77(3.1) 82(2.8) 66(0.8)**
Antrum(SE) 152(2.8) 67(1.2) 44(1.6) 41(1.9) 40(1.5)***
Duodenum(SE) 220(6.6) 184(4.1) 79(2.9) 46(1.4) 48(1/9)***'
*NS^=0.65
**p<0.008
***p<0.02
****p<b.016
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Figure 8
Blood flow&Pulse in one rabbit receiving octreotide
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Discussion
This study demonstrated that LDF can be used to measure GDMBF 
easily , directly and continuously in experimental animals . Octreotide 
decreased GDMBF and intragastric acidity without causing systemic 
haemodynamic changes . A dose-response relationship between GDMBF 
and octreotide concentration was demonstrated , although this was 
clearer for gastric mucosal blood flow than duodenal blood flow . 
Vasopressin was used as a positive control since it is known that it 
decreases GDMBF , although as expected its use was associated with 
significant haemodynamic changes . Such changes did not occur 
following octreotide infusion .
The mechanisms of action of octreotide on GDMBF is unknown . It may 
be a direct consequence of decreasing splanclinic blood flow , a direct 
vascular effect or an indirect effect mediated by suppression of 
vasoactive intestinal hormones .
Many problems were encountered by previous researchers when 
measuring GDMBF . Previous methods were invasive , indirect, not 
reproducible and were not applicable to man . Becker et al (1982) found 
that somatostatin significantly decreases gastric but not duodenal blood 
flow . They and others(Staiiinger et al 1987) used the radioactive 
microspheres method of assessing blood flow which allowed 
measurements for only a few minutes . These measurements do not 
represent focal blood flow but are a measure of total gastric tissue
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perflision . Furthermore this method requires the animals to be killed 
before assessment of blood flow can be histologically determined . 
GDMBF has been measured by neutral red clearance (Sonnenberg et al 
1983). This method is also invasive and indirect, necessitating 
intravenous injection of neutral red , multiple venous blood sampling , 
naso-gastric aspiration of gastric contents for analysis and complicated 
calculations .
In contrast LDF is a validated method of measuring GMBF (Sato et al 
1995 , Gana et al 1987) . It is non invasive , easy to use , safe with 
excellent reproducibility and can be used in man (Lunde et al 1988).
The teclmique allows repeated measurement of blood flow without 
access to venous or arterial blood . It offers instantaneous and continuous 
focal blood flow measurement. The main disadvantages are 
maintenance of probe-mucosa contact and the lack of calibration in 
absolute flow values . In fact probe-mucosal proximity can be easily 
maintained both at gastrostomy and endoscopy with minimal practice 
and reproducible values can be obtained . Unfortunately the arbitrary 
values for blood flow cannot be translated to actual blood flow(mls/min) 
because the doppler signal reflects velocity rather than volume . The 
LDF is therefore most useful for defining changes in blood flow 
following specific intervention.
The relationship between intagastric acidity and GDMBF is uncertain . 
Previous studies have demonstrated a positive relationship between
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GDMBF and acid concentration up to a value of 80inM , beyond which 
the relationship becomes negative (Starlinger et al 1987&1981) . The 
observation that octreotide infusion was associated with increased 
intragastric pH was an incidental finding in this study and frirther 
assessment of this relationship using more accurate measurements of 
gastric acid secretion is warranted .
This study does suggest that octreotide infusion could be of value in the 
treatment of mucosal bleeding from the upper gastrointestinal tract and 
further clinical and pharmacological studies are necessary .
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Chapter 7
Sum m ary , Conclusions and Future Plans
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Peptic ulcer haemorrhage remains a common problem in clinical practice 
and continues to present challenges to clinicians .
Endoscopic therapy is now well established as a very useful and often a first 
line method of managing high risk patients who present with major peptic 
ulcer haemorrhage and active bleeding or non bleeding visible vessels . 
Endoscopic injection therapy is effective in a majority of patients . 
Furthermore this method appears to be easy to use , cheap and accessible to 
most units .
I have demonstrated that injection therapy using a combination of adrenaline 
plus human thrombin is an effective modality ; in experimental animals it 
proved to be the most potent agent in stopping bleeding and in my clinical 
trial it stopped active bleeding and prevented rebleeding in over 95% of 
patients without causing complications .
The experimental bleeding model studies also confirmed that sclerosants are 
ineffective in stopping active bleeding and induce tissue necrosis .
Therefore since published clinical trials do not demonstrate an additional 
specific benefit for sclerosants , their use should be abandoned in clinical 
practice .
The bleeding ulcer model I used in my research remains far removed fiom 
the human scenario of a clironic ulcer with a large vessel in its base , 
therefore my successors should attempt to create new ulcer models . This 
may be attempted by repeated endoscopic injections of 98% alcohol into the 
gastroduodenal mucosa of animals and could be linked to the administration
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of NSAIDs and anticoagulants over a longer period of time . I have already 
designed the protocol for such a study .
Although I have demonstrated that a combination of adrenaline plus 
tlii'ombin is superior to adrenaline alone in treating patients who present 
with major peptic ulcer haemorrhage , this needs to be confirmed in a larger 
study. Such a study could be further improved if it was double blinded i.e. if 
an inert solution is injected in stead of thrombin into the bleeding vessel of 
ulcers in the control(adrenaline alone) group . Fmthermore the issue of 
safety of human thrombin should be further addressed . In order to study the 
systemic effect of tlirombin upon the coagulation factors present in the 
circulation I collected venous blood samples from 24 patients randomised to 
adrenaline plus thrombin and 12 controls (patients receiving adrenaline 
alone). This was done before and 20 minutes after injection therapy .
Colleagues at the Scottish Blood Transftision Service are assessing the 
concentration of d Dimers , thrombin/ antithiombin complexes and alpha 
thrombin in these samples and I hope and believe that this study will be the 
subject of future publications .
The optimum concentration of tlirombin which should be used in clinical 
practice should be adequately assessed . This may be carried out by injection 
of different doses of thi'ombin into clamped serosal vessels of animals and 
or into synthetic vessels of known size .
Surgery remains an important tool in the management of patients in whom 
endoscopic therapy is not possible or those who continue to bleed or rebleed
I
despite endoscopic therapy . My retrospective analysis of the outcome of
?
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surgery for peptic ulcer haemorrhage in the Lothian region since the advent 
of endoscopic therapy showed that underrunning of the bleeding vessel 
alone is associated with a high rebleeding rate and is associated with high 
morbidity and mortality. However these results must be treated (like those 
of any retrospective analysis) with caution . Negotiations are underway to 
design a randomised controlled trial to compare underrunning alone with 
definitive ulcer surgery. Furthermore there is a growing suspicion that we 
are witnessing an atrophy of surgical experience with ulcer surgery which 
may be related to poorer outcome reported after surgery in this extremely 
high risk population . This will inevitably contribute to the debate 
concerning the development of bleeding units staffed by experienced 
gastroenterologists and surgeons with special interest in upper 
gastrointestinal bleeding .
Reduced long term survival of patients who survive a hospital admission for 
major peptic ulcer haemorrhage is a reflection an elderly population with 
many comorbid diseases . It is reassuring to find that endoscopic therapy 
was not associated with increased long term morbidity or mortality . The 
observation that dyspepsia is uncommon amongst patients who have late 
recurrent ulcer bleeding has important implications for follow up in this 
group since secondary prophylactic treatment couldnot be based upon 
symptoms . This adds to the debate regarding optimum prophylaxis against 
ulcer bleeding and may open the way to a multi-centre trial in the north and 
east of Scotland comparing conventional acid reducing long term 
prophylaxis versus helicobacter pylori eradication therapy .
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Laser Doppler Flowmetry represents the method of choice for assessing 
gastroduodenal perflision in animals and man . My successor plans to study 
the effect of injection therapy upon GDMBF in patients being treated for 
major peptic ulcer haemorrhage . This may reveal important information 
concerning vasoconstriction, tissue oedema and arterial thrombosis 
following injection. •
The role of gastroduodenal blood flow in ulcer genesis and healing may be 
important. Therefore I have already started a clinical study to measure 
gastroduodenal mucosal blood flow in patients with ulcer disease , 
comparing GDMBF between the centre and periphery of the ulcerated 
lesions .
For those patients who fail endoscopic therapy and are deemed unfit for 
surgical intervention the risk of death is grave . Therefore the search must 
continue for an agent which may stop bleeding . Octreotide was useful in 
treating such patients in my own practice but inevitably the number of 
patients involved is very sm all. I have personally used intravenous 
octreotide infusion in the treatment of four patients with uncontrolled ulcer 
haemorrhage who were deemed imfit for surgery with encouraging success 
(4 out of 4) (see publication list for a case report on this matter in press). 
Clearly further research is required in this field
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